<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:06d9d42d-425d-46af-b644-2caa58279f83,g:66209aa8-fa97-41b8-9976-1e217b17d88c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://c4therapeutics.com/role/Cover" xlink:type="simple" xlink:href="cccc-20240331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c40097a5-970b-4af3-87e5-f54716fd35a4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_DocumentType_c40097a5-970b-4af3-87e5-f54716fd35a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_176ad092-f2f8-4468-8ff3-ddeb090b9c7d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_DocumentQuarterlyReport_176ad092-f2f8-4468-8ff3-ddeb090b9c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_75d95895-c019-4add-a361-8c23adcfb826" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_DocumentPeriodEndDate_75d95895-c019-4add-a361-8c23adcfb826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d1b82458-fb53-4e19-a59b-7b56f6d1ecf8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_DocumentTransitionReport_d1b82458-fb53-4e19-a59b-7b56f6d1ecf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7ad92895-3eea-4f7f-9fc1-40e030cfc8fa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_DocumentFiscalYearFocus_7ad92895-3eea-4f7f-9fc1-40e030cfc8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_22b18a8a-9fbc-44ab-9433-a5b9cb8a9170" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_22b18a8a-9fbc-44ab-9433-a5b9cb8a9170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e32e4b90-1c73-4da0-8bbe-362d4ecd266f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_CurrentFiscalYearEndDate_e32e4b90-1c73-4da0-8bbe-362d4ecd266f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2a6d51c3-15a1-4155-9514-bc9f20793c9c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityFileNumber_2a6d51c3-15a1-4155-9514-bc9f20793c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_70fe7664-6e9e-4d07-b493-e2b159dab2ba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityRegistrantName_70fe7664-6e9e-4d07-b493-e2b159dab2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_715aa62f-aa02-452d-bead-351478365395" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_715aa62f-aa02-452d-bead-351478365395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e6a8cf5b-8b51-4dd1-a0ab-381ce9990b78" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityTaxIdentificationNumber_e6a8cf5b-8b51-4dd1-a0ab-381ce9990b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_6cc2f3f8-1a8f-4ad2-a298-49bbbd983a61" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityAddressAddressLine1_6cc2f3f8-1a8f-4ad2-a298-49bbbd983a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_00505951-af8c-43b3-ae89-60dcc59ddb20" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityAddressAddressLine2_00505951-af8c-43b3-ae89-60dcc59ddb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3096958f-9852-40ea-a1a0-3ecc1e22a726" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityAddressCityOrTown_3096958f-9852-40ea-a1a0-3ecc1e22a726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_514208ac-fd90-4621-8519-eba919522286" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityAddressStateOrProvince_514208ac-fd90-4621-8519-eba919522286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4c001fb7-0a65-4741-94c3-ee961a8cb57a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityAddressPostalZipCode_4c001fb7-0a65-4741-94c3-ee961a8cb57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e26ce15f-cca8-450e-be82-8a892c48214f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_CityAreaCode_e26ce15f-cca8-450e-be82-8a892c48214f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e2eaabc4-665c-4654-ade0-052faa1abf74" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_LocalPhoneNumber_e2eaabc4-665c-4654-ade0-052faa1abf74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b4db162a-1a9e-4e33-b818-42e4df1a0232" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_Security12bTitle_b4db162a-1a9e-4e33-b818-42e4df1a0232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2a4535f7-ef81-4737-9af3-e624716f19f8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_TradingSymbol_2a4535f7-ef81-4737-9af3-e624716f19f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7782a3d4-c732-424b-a682-8b6f4510acf9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_SecurityExchangeName_7782a3d4-c732-424b-a682-8b6f4510acf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_cc900716-905b-49c1-9ec8-3f38b8b91ccc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityCurrentReportingStatus_cc900716-905b-49c1-9ec8-3f38b8b91ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e13f5779-086d-42da-93ff-36e4bb5eb6be" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityInteractiveDataCurrent_e13f5779-086d-42da-93ff-36e4bb5eb6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9683af2c-e5d2-4d44-bdd0-656d8e34c738" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityFilerCategory_9683af2c-e5d2-4d44-bdd0-656d8e34c738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_37f24a60-d222-4c33-983c-61829d804c31" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntitySmallBusiness_37f24a60-d222-4c33-983c-61829d804c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_19c0c0f1-af61-47b5-a8fc-a23eb716edd1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityEmergingGrowthCompany_19c0c0f1-af61-47b5-a8fc-a23eb716edd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_41e3b91f-e71e-4bde-a6d9-d0acd0801c1d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityShellCompany_41e3b91f-e71e-4bde-a6d9-d0acd0801c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_cb1d983e-6731-47cc-a741-e31391ab2144" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_cb1d983e-6731-47cc-a741-e31391ab2144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fae79179-013c-4a3c-b5b8-2b3a4f899ced" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_EntityCentralIndexKey_fae79179-013c-4a3c-b5b8-2b3a4f899ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d9050c5c-58fa-43bc-b634-6d16d3dea7e7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9faa99fd-d2db-4930-9302-453884111ed5" xlink:to="loc_dei_AmendmentFlag_d9050c5c-58fa-43bc-b634-6d16d3dea7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cccc-20240331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_147bf1cc-205e-4c0f-b159-796b257d9f54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_555e09a0-b016-4f4e-bac8-ab224bd69583" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_147bf1cc-205e-4c0f-b159-796b257d9f54" xlink:to="loc_us-gaap_AssetsAbstract_555e09a0-b016-4f4e-bac8-ab224bd69583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_3a4fdc29-0ddd-4f2b-85cb-e081929b9f83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_555e09a0-b016-4f4e-bac8-ab224bd69583" xlink:to="loc_us-gaap_AssetsCurrentAbstract_3a4fdc29-0ddd-4f2b-85cb-e081929b9f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fc6b7cbc-17ab-4b5d-ac56-f8171e66f021" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3a4fdc29-0ddd-4f2b-85cb-e081929b9f83" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fc6b7cbc-17ab-4b5d-ac56-f8171e66f021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_3cc49251-3166-426e-8d79-d412013e4093" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3a4fdc29-0ddd-4f2b-85cb-e081929b9f83" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_3cc49251-3166-426e-8d79-d412013e4093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_27ee45b7-b554-47a6-99e0-a215224e46e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3a4fdc29-0ddd-4f2b-85cb-e081929b9f83" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_27ee45b7-b554-47a6-99e0-a215224e46e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4ac702bd-de86-4e5d-9f94-b546d61878ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3a4fdc29-0ddd-4f2b-85cb-e081929b9f83" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4ac702bd-de86-4e5d-9f94-b546d61878ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_73b11bb2-6a0d-434e-96bd-3f4bc89398d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3a4fdc29-0ddd-4f2b-85cb-e081929b9f83" xlink:to="loc_us-gaap_AssetsCurrent_73b11bb2-6a0d-434e-96bd-3f4bc89398d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_76da1245-503f-4897-8299-ddedab7c604e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_555e09a0-b016-4f4e-bac8-ab224bd69583" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_76da1245-503f-4897-8299-ddedab7c604e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_38601dfd-be6f-4b21-a644-5f93cefc40b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_555e09a0-b016-4f4e-bac8-ab224bd69583" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_38601dfd-be6f-4b21-a644-5f93cefc40b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_efd2f4ff-400e-47ed-95c6-68a66b27d178" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_555e09a0-b016-4f4e-bac8-ab224bd69583" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_efd2f4ff-400e-47ed-95c6-68a66b27d178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_122302e3-da92-46ce-b36e-1f17f9118c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_555e09a0-b016-4f4e-bac8-ab224bd69583" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_122302e3-da92-46ce-b36e-1f17f9118c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f86199e9-7e69-413b-a0a4-2c273ddb6ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_555e09a0-b016-4f4e-bac8-ab224bd69583" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f86199e9-7e69-413b-a0a4-2c273ddb6ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_89fb7ef3-8f90-418c-9937-c0933b3bc1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_555e09a0-b016-4f4e-bac8-ab224bd69583" xlink:to="loc_us-gaap_Assets_89fb7ef3-8f90-418c-9937-c0933b3bc1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d89e1bdd-1545-4568-bec3-5a6eb3a6d273" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_147bf1cc-205e-4c0f-b159-796b257d9f54" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d89e1bdd-1545-4568-bec3-5a6eb3a6d273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_60834e81-de65-4c5e-8d60-beb6ca520a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d89e1bdd-1545-4568-bec3-5a6eb3a6d273" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_60834e81-de65-4c5e-8d60-beb6ca520a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a3314773-80e6-4a82-87a0-b2a5ee9b5c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_60834e81-de65-4c5e-8d60-beb6ca520a0b" xlink:to="loc_us-gaap_AccountsPayableCurrent_a3314773-80e6-4a82-87a0-b2a5ee9b5c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_df651ed1-8154-4992-abff-b41a4d7c38a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_60834e81-de65-4c5e-8d60-beb6ca520a0b" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_df651ed1-8154-4992-abff-b41a4d7c38a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d28e79ce-981a-4308-ac48-fb73a77140d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_60834e81-de65-4c5e-8d60-beb6ca520a0b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d28e79ce-981a-4308-ac48-fb73a77140d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_53c27eaa-1297-4f18-85b0-657854768c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_60834e81-de65-4c5e-8d60-beb6ca520a0b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_53c27eaa-1297-4f18-85b0-657854768c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f2caee40-e0a7-445b-85fd-d5aa61830ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_60834e81-de65-4c5e-8d60-beb6ca520a0b" xlink:to="loc_us-gaap_LiabilitiesCurrent_f2caee40-e0a7-445b-85fd-d5aa61830ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7627268a-2593-4b68-8f08-5ab70c371c35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d89e1bdd-1545-4568-bec3-5a6eb3a6d273" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7627268a-2593-4b68-8f08-5ab70c371c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_321bf981-cc83-4e9d-b80e-e40a9d7597f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d89e1bdd-1545-4568-bec3-5a6eb3a6d273" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_321bf981-cc83-4e9d-b80e-e40a9d7597f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bff70e51-0cba-4113-82b3-39393495385f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d89e1bdd-1545-4568-bec3-5a6eb3a6d273" xlink:to="loc_us-gaap_Liabilities_bff70e51-0cba-4113-82b3-39393495385f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1bf9cce5-59ac-40d3-ab98-bbd6fbc771f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d89e1bdd-1545-4568-bec3-5a6eb3a6d273" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1bf9cce5-59ac-40d3-ab98-bbd6fbc771f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_5427956c-4230-42c4-a849-ad6212d6047a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d89e1bdd-1545-4568-bec3-5a6eb3a6d273" xlink:to="loc_us-gaap_StockholdersEquityAbstract_5427956c-4230-42c4-a849-ad6212d6047a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_aa51a17f-a00c-4849-bf29-3fff4db08b60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5427956c-4230-42c4-a849-ad6212d6047a" xlink:to="loc_us-gaap_PreferredStockValue_aa51a17f-a00c-4849-bf29-3fff4db08b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9cd477a9-7fd7-47da-ae44-42f09d53e5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5427956c-4230-42c4-a849-ad6212d6047a" xlink:to="loc_us-gaap_CommonStockValue_9cd477a9-7fd7-47da-ae44-42f09d53e5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5a862a6a-5a2b-45cb-b3a4-044f586aa0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5427956c-4230-42c4-a849-ad6212d6047a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5a862a6a-5a2b-45cb-b3a4-044f586aa0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4ae0ccc5-23e7-49d9-8499-84cb4819805f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5427956c-4230-42c4-a849-ad6212d6047a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4ae0ccc5-23e7-49d9-8499-84cb4819805f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_27843bc1-09b9-41e8-b387-8afda7cc4a92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5427956c-4230-42c4-a849-ad6212d6047a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_27843bc1-09b9-41e8-b387-8afda7cc4a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a49b2fa6-b618-4eb0-83ff-8c3bc6e3b92a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5427956c-4230-42c4-a849-ad6212d6047a" xlink:to="loc_us-gaap_StockholdersEquity_a49b2fa6-b618-4eb0-83ff-8c3bc6e3b92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_368b1f3d-1a7a-4b8f-85a3-7c52009e8778" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d89e1bdd-1545-4568-bec3-5a6eb3a6d273" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_368b1f3d-1a7a-4b8f-85a3-7c52009e8778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cccc-20240331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_b6446695-17cb-4f54-97bc-c1f5c0d02efd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_de6c02f3-ef83-4626-9a39-5c2d859992f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b6446695-17cb-4f54-97bc-c1f5c0d02efd" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_de6c02f3-ef83-4626-9a39-5c2d859992f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_0d3af6b6-40d6-4f75-be38-7c852aa3bb88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b6446695-17cb-4f54-97bc-c1f5c0d02efd" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_0d3af6b6-40d6-4f75-be38-7c852aa3bb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3046f970-34db-4c54-986a-35f25c95277f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b6446695-17cb-4f54-97bc-c1f5c0d02efd" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3046f970-34db-4c54-986a-35f25c95277f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_ccc6a779-2c9e-4726-ba6e-b44d6a7cacc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b6446695-17cb-4f54-97bc-c1f5c0d02efd" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_ccc6a779-2c9e-4726-ba6e-b44d6a7cacc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_020e586c-9d3c-4a2c-a50b-7203ace303ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b6446695-17cb-4f54-97bc-c1f5c0d02efd" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_020e586c-9d3c-4a2c-a50b-7203ace303ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5d10605f-0da2-4fd5-8278-1d20c137af37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b6446695-17cb-4f54-97bc-c1f5c0d02efd" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5d10605f-0da2-4fd5-8278-1d20c137af37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b526f85f-144a-4b8a-890b-9a0a1698e880" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b6446695-17cb-4f54-97bc-c1f5c0d02efd" xlink:to="loc_us-gaap_CommonStockSharesIssued_b526f85f-144a-4b8a-890b-9a0a1698e880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a9a67b03-150a-4b1a-86e6-d8f95aa5ae80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_b6446695-17cb-4f54-97bc-c1f5c0d02efd" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a9a67b03-150a-4b1a-86e6-d8f95aa5ae80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="cccc-20240331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_82992446-c3a9-4271-bbd6-2dd661a01974" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_82992446-c3a9-4271-bbd6-2dd661a01974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4dc6dc7d-c2f0-4f06-9d91-bc848db11123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4dc6dc7d-c2f0-4f06-9d91-bc848db11123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4bbc776d-f543-40c7-8011-12fb4f206b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4dc6dc7d-c2f0-4f06-9d91-bc848db11123" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4bbc776d-f543-40c7-8011-12fb4f206b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1545da70-7c7c-4aad-b6ca-167a0b2a3a17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4dc6dc7d-c2f0-4f06-9d91-bc848db11123" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1545da70-7c7c-4aad-b6ca-167a0b2a3a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_75ff72e4-ef34-4ecc-bada-7c28f6a190af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4dc6dc7d-c2f0-4f06-9d91-bc848db11123" xlink:to="loc_us-gaap_RestructuringCosts_75ff72e4-ef34-4ecc-bada-7c28f6a190af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_358945cf-1d1b-48b1-8119-2a97c86a2ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4dc6dc7d-c2f0-4f06-9d91-bc848db11123" xlink:to="loc_us-gaap_OperatingExpenses_358945cf-1d1b-48b1-8119-2a97c86a2ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d8db836a-45c2-4dd3-a7de-8bb13c023213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_OperatingIncomeLoss_d8db836a-45c2-4dd3-a7de-8bb13c023213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3151bd6b-0f92-489e-ae35-fb1f704bed61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3151bd6b-0f92-489e-ae35-fb1f704bed61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_InterestExpenseAndAmortizationOfLongTermDebtRelatedParty_0391c655-0e6b-4b81-8fac-fb2f7eaa0eaa" xlink:href="cccc-20240331.xsd#cccc_InterestExpenseAndAmortizationOfLongTermDebtRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3151bd6b-0f92-489e-ae35-fb1f704bed61" xlink:to="loc_cccc_InterestExpenseAndAmortizationOfLongTermDebtRelatedParty_0391c655-0e6b-4b81-8fac-fb2f7eaa0eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_01ed454e-ac5e-4fbd-ac7c-177e2c0bbabc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3151bd6b-0f92-489e-ae35-fb1f704bed61" xlink:to="loc_us-gaap_InterestAndOtherIncome_01ed454e-ac5e-4fbd-ac7c-177e2c0bbabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_69454393-b7ed-4df1-896b-f6b11ff0b1da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_3151bd6b-0f92-489e-ae35-fb1f704bed61" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_69454393-b7ed-4df1-896b-f6b11ff0b1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ffb6a6b6-8921-4853-995d-ca35cfcf7dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ffb6a6b6-8921-4853-995d-ca35cfcf7dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4a319308-3b06-422e-a1d0-97b7ac8ba750" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4a319308-3b06-422e-a1d0-97b7ac8ba750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1871d6f9-1768-4a89-84f2-8404239eb217" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_NetIncomeLoss_1871d6f9-1768-4a89-84f2-8404239eb217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b50560a5-b78d-4868-a775-51474336cc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_EarningsPerShareBasic_b50560a5-b78d-4868-a775-51474336cc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1bcf792e-7613-4992-89e1-14a98bea159a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1bcf792e-7613-4992-89e1-14a98bea159a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0bfddf05-9fb7-4188-9c31-c89da897ec49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0bfddf05-9fb7-4188-9c31-c89da897ec49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2cb238ac-6379-4753-b397-0a60d051daf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2cb238ac-6379-4753-b397-0a60d051daf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c175c90b-1e73-45e8-8460-d472e362efb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c175c90b-1e73-45e8-8460-d472e362efb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_aaf7d565-1281-4a99-bab7-2e515e6a4384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c175c90b-1e73-45e8-8460-d472e362efb9" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_aaf7d565-1281-4a99-bab7-2e515e6a4384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6315cce1-4fb6-495f-b4a8-ea6fc9ce4f08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c175c90b-1e73-45e8-8460-d472e362efb9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_6315cce1-4fb6-495f-b4a8-ea6fc9ce4f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_c24ec0a4-f400-4a5f-84cd-b9eb5c44091a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_dd56b249-f59d-48d7-89c1-cb9413c2cbd7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_c24ec0a4-f400-4a5f-84cd-b9eb5c44091a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="cccc-20240331.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_874d4176-a7ea-42b5-bad5-14d2a0672fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d56f4f42-2fbc-4fbb-ae40-9602799312ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_874d4176-a7ea-42b5-bad5-14d2a0672fa9" xlink:to="loc_us-gaap_StatementTable_d56f4f42-2fbc-4fbb-ae40-9602799312ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c655b46a-f269-42ee-918e-423ecdf85c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d56f4f42-2fbc-4fbb-ae40-9602799312ac" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c655b46a-f269-42ee-918e-423ecdf85c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f8ebde11-7121-46d8-b6bc-99a78108ccb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c655b46a-f269-42ee-918e-423ecdf85c5b" xlink:to="loc_us-gaap_EquityComponentDomain_f8ebde11-7121-46d8-b6bc-99a78108ccb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_31698847-6b70-497b-9d02-145a52635f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f8ebde11-7121-46d8-b6bc-99a78108ccb6" xlink:to="loc_us-gaap_CommonStockMember_31698847-6b70-497b-9d02-145a52635f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_83e57aad-6a7c-42cd-ac1f-31000995be6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f8ebde11-7121-46d8-b6bc-99a78108ccb6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_83e57aad-6a7c-42cd-ac1f-31000995be6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_be3576e3-ca20-4044-92ee-ab97473c649b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f8ebde11-7121-46d8-b6bc-99a78108ccb6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_be3576e3-ca20-4044-92ee-ab97473c649b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e6f41eea-3ecc-4d0d-a691-3e82c60134d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f8ebde11-7121-46d8-b6bc-99a78108ccb6" xlink:to="loc_us-gaap_RetainedEarningsMember_e6f41eea-3ecc-4d0d-a691-3e82c60134d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ceb08c8b-bdd7-474a-a474-040afd214a15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d56f4f42-2fbc-4fbb-ae40-9602799312ac" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ceb08c8b-bdd7-474a-a474-040afd214a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_090cae53-1922-4310-b4a0-8278ec883b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ceb08c8b-bdd7-474a-a474-040afd214a15" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_090cae53-1922-4310-b4a0-8278ec883b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_StockPurchaseAgreementMember_be935ba4-a434-487b-be75-81416dd3ee1c" xlink:href="cccc-20240331.xsd#cccc_StockPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_090cae53-1922-4310-b4a0-8278ec883b3f" xlink:to="loc_cccc_StockPurchaseAgreementMember_be935ba4-a434-487b-be75-81416dd3ee1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AtTheMarketMember_81952a1a-4485-4de3-bf09-e540151346e9" xlink:href="cccc-20240331.xsd#cccc_AtTheMarketMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_090cae53-1922-4310-b4a0-8278ec883b3f" xlink:to="loc_cccc_AtTheMarketMember_81952a1a-4485-4de3-bf09-e540151346e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_862a187c-b9e6-42ae-b836-6fad8f114047" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d56f4f42-2fbc-4fbb-ae40-9602799312ac" xlink:to="loc_us-gaap_StatementLineItems_862a187c-b9e6-42ae-b836-6fad8f114047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_862a187c-b9e6-42ae-b836-6fad8f114047" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2aad1b6a-b7f0-4c88-a78a-1812e27ee0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_SharesOutstanding_2aad1b6a-b7f0-4c88-a78a-1812e27ee0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9dc64a84-59bb-492b-9f49-ddc2a8487238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_StockholdersEquity_9dc64a84-59bb-492b-9f49-ddc2a8487238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ce40c496-f59b-4112-ad5a-c154feac0189" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_ce40c496-f59b-4112-ad5a-c154feac0189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fd0807cf-1e72-4578-b804-d1d6092526ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fd0807cf-1e72-4578-b804-d1d6092526ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2c4fecd4-e34f-4dde-b847-8d0081ebb184" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2c4fecd4-e34f-4dde-b847-8d0081ebb184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a6f46471-088a-4a65-8a70-8ba6003d0986" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a6f46471-088a-4a65-8a70-8ba6003d0986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_63520e76-2682-4a9f-bd3d-10e267c909d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_63520e76-2682-4a9f-bd3d-10e267c909d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f6f5806f-dfd4-40fb-987d-ac1a2cb03c91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f6f5806f-dfd4-40fb-987d-ac1a2cb03c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f426a48b-72b6-4856-8160-d81e1ee2c63d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f426a48b-72b6-4856-8160-d81e1ee2c63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0a0ac4bc-92a0-4491-9762-b37015d8969e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_0a0ac4bc-92a0-4491-9762-b37015d8969e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_91c5ab44-76f0-4384-a327-9f32d78b662d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_91c5ab44-76f0-4384-a327-9f32d78b662d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_ab65c8e2-1004-4286-9684-3f705cb8b110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_ab65c8e2-1004-4286-9684-3f705cb8b110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ce0fdb7b-a00a-44b4-a6b6-8990b22f1a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_NetIncomeLoss_ce0fdb7b-a00a-44b4-a6b6-8990b22f1a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AdjustmentsToAdditionalPaidInCapitalOtherShares_944dd5f2-9945-4dc9-9e64-5cde38a0d3e3" xlink:href="cccc-20240331.xsd#cccc_AdjustmentsToAdditionalPaidInCapitalOtherShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_cccc_AdjustmentsToAdditionalPaidInCapitalOtherShares_944dd5f2-9945-4dc9-9e64-5cde38a0d3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_c8b19969-cd9e-4110-91d6-9ce64fc0a936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_c8b19969-cd9e-4110-91d6-9ce64fc0a936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_528e7304-ba31-4f8d-b645-5cb4eeed20db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_SharesOutstanding_528e7304-ba31-4f8d-b645-5cb4eeed20db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cb9296e7-82ce-4475-8196-4e24d4e15a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a129c3ca-d500-4586-9faf-b6690ae7866f" xlink:to="loc_us-gaap_StockholdersEquity_cb9296e7-82ce-4475-8196-4e24d4e15a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cccc-20240331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f54b580e-93b1-4142-8d61-7537e020867a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2e4459c4-7a9c-4c76-a1aa-955e2f55cbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f54b580e-93b1-4142-8d61-7537e020867a" xlink:to="loc_us-gaap_StatementTable_2e4459c4-7a9c-4c76-a1aa-955e2f55cbfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_484be539-c217-4732-9dd1-4ffe6e7c3f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2e4459c4-7a9c-4c76-a1aa-955e2f55cbfd" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_484be539-c217-4732-9dd1-4ffe6e7c3f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77718f76-0841-470e-a628-aab8e34f3731" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_484be539-c217-4732-9dd1-4ffe6e7c3f3d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77718f76-0841-470e-a628-aab8e34f3731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_StockPurchaseAgreementMember_3e1ca2a2-ff00-41d8-b352-2cfebf6efb98" xlink:href="cccc-20240331.xsd#cccc_StockPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77718f76-0841-470e-a628-aab8e34f3731" xlink:to="loc_cccc_StockPurchaseAgreementMember_3e1ca2a2-ff00-41d8-b352-2cfebf6efb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AtTheMarketMember_a2ffc149-334d-4787-8ff4-5d6c21cad0b4" xlink:href="cccc-20240331.xsd#cccc_AtTheMarketMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_77718f76-0841-470e-a628-aab8e34f3731" xlink:to="loc_cccc_AtTheMarketMember_a2ffc149-334d-4787-8ff4-5d6c21cad0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ad8d124b-260e-45bf-ac2b-17e26c4c6115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2e4459c4-7a9c-4c76-a1aa-955e2f55cbfd" xlink:to="loc_us-gaap_StatementLineItems_ad8d124b-260e-45bf-ac2b-17e26c4c6115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7712deef-917f-46f6-b402-b251d6488c25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad8d124b-260e-45bf-ac2b-17e26c4c6115" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7712deef-917f-46f6-b402-b251d6488c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9315a7d6-4bdf-40ed-886b-e891552d5acd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7712deef-917f-46f6-b402-b251d6488c25" xlink:to="loc_us-gaap_ProfitLoss_9315a7d6-4bdf-40ed-886b-e891552d5acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56b2f5ea-6601-4e4a-9258-35fae9bd5e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7712deef-917f-46f6-b402-b251d6488c25" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56b2f5ea-6601-4e4a-9258-35fae9bd5e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e8003e9b-0279-4d2a-8475-7bd667e2f0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56b2f5ea-6601-4e4a-9258-35fae9bd5e3c" xlink:to="loc_us-gaap_ShareBasedCompensation_e8003e9b-0279-4d2a-8475-7bd667e2f0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d97e25d3-1a6a-441c-86f4-594e5d9f4a88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56b2f5ea-6601-4e4a-9258-35fae9bd5e3c" xlink:to="loc_us-gaap_Depreciation_d97e25d3-1a6a-441c-86f4-594e5d9f4a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_62e4ff46-e5c0-40f1-aa10-56f24e129985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56b2f5ea-6601-4e4a-9258-35fae9bd5e3c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_62e4ff46-e5c0-40f1-aa10-56f24e129985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_81862518-3b43-421c-9c38-1bfbe1e1612b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56b2f5ea-6601-4e4a-9258-35fae9bd5e3c" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_81862518-3b43-421c-9c38-1bfbe1e1612b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_f9ac6b1e-c6bc-48ab-80ce-5f970a9e8bce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56b2f5ea-6601-4e4a-9258-35fae9bd5e3c" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_f9ac6b1e-c6bc-48ab-80ce-5f970a9e8bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_b58c8591-ce09-4126-bb92-7780a96b60b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_56b2f5ea-6601-4e4a-9258-35fae9bd5e3c" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_b58c8591-ce09-4126-bb92-7780a96b60b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4a55408a-8b73-4d3b-b2a0-de0332b34a71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7712deef-917f-46f6-b402-b251d6488c25" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4a55408a-8b73-4d3b-b2a0-de0332b34a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_cdf5e704-8e7a-44c9-97c5-ef0b5dcfb6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4a55408a-8b73-4d3b-b2a0-de0332b34a71" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_cdf5e704-8e7a-44c9-97c5-ef0b5dcfb6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3087067f-92ad-47bf-92c8-ed8f7b563a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4a55408a-8b73-4d3b-b2a0-de0332b34a71" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3087067f-92ad-47bf-92c8-ed8f7b563a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_793b246b-7194-41e7-9bfd-a4af98573198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4a55408a-8b73-4d3b-b2a0-de0332b34a71" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_793b246b-7194-41e7-9bfd-a4af98573198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_dd16d98f-0cb2-4c48-aca8-c9643efa7834" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4a55408a-8b73-4d3b-b2a0-de0332b34a71" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_dd16d98f-0cb2-4c48-aca8-c9643efa7834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_13a88eb1-0eb2-4845-a0db-604dec1869b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4a55408a-8b73-4d3b-b2a0-de0332b34a71" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_13a88eb1-0eb2-4845-a0db-604dec1869b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_55ebcf3a-a084-4e65-badc-55304c3e280d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4a55408a-8b73-4d3b-b2a0-de0332b34a71" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_55ebcf3a-a084-4e65-badc-55304c3e280d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_43f8bca9-ff3a-48b2-b4d3-397e74ad5fad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7712deef-917f-46f6-b402-b251d6488c25" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_43f8bca9-ff3a-48b2-b4d3-397e74ad5fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_479ef63e-773c-4c42-a363-f833cb40769d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad8d124b-260e-45bf-ac2b-17e26c4c6115" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_479ef63e-773c-4c42-a363-f833cb40769d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_4db90530-f286-46bc-8fcd-3a58829f5045" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_479ef63e-773c-4c42-a363-f833cb40769d" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_4db90530-f286-46bc-8fcd-3a58829f5045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_44e13fcc-33d2-4c82-b496-16f849aaf674" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_479ef63e-773c-4c42-a363-f833cb40769d" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_44e13fcc-33d2-4c82-b496-16f849aaf674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ac13e974-1b16-4feb-b24d-d40c01368336" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_479ef63e-773c-4c42-a363-f833cb40769d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ac13e974-1b16-4feb-b24d-d40c01368336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ba58221a-7e5d-4d29-a2cd-04b04be70b25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_479ef63e-773c-4c42-a363-f833cb40769d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ba58221a-7e5d-4d29-a2cd-04b04be70b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2f02b987-e222-4f5e-99bb-f65d8ab2513f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad8d124b-260e-45bf-ac2b-17e26c4c6115" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2f02b987-e222-4f5e-99bb-f65d8ab2513f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dab35c1c-593e-407e-9677-6e05cef0c6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2f02b987-e222-4f5e-99bb-f65d8ab2513f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dab35c1c-593e-407e-9677-6e05cef0c6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ad433016-ef28-40bf-aae4-3c0e1f91c689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2f02b987-e222-4f5e-99bb-f65d8ab2513f" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ad433016-ef28-40bf-aae4-3c0e1f91c689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_47bd461a-b7d7-41bf-b8b4-842ea5d206f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2f02b987-e222-4f5e-99bb-f65d8ab2513f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_47bd461a-b7d7-41bf-b8b4-842ea5d206f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_6334cb94-9351-492d-a9a7-8a312bf46124" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2f02b987-e222-4f5e-99bb-f65d8ab2513f" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_6334cb94-9351-492d-a9a7-8a312bf46124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_264f795c-d4ca-413e-b8a8-3897f41ec58e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2f02b987-e222-4f5e-99bb-f65d8ab2513f" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_264f795c-d4ca-413e-b8a8-3897f41ec58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_11619a4f-c465-4209-b737-9e4220288407" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2f02b987-e222-4f5e-99bb-f65d8ab2513f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_11619a4f-c465-4209-b737-9e4220288407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ab593803-7c9b-47a9-8725-ceaeb107a3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad8d124b-260e-45bf-ac2b-17e26c4c6115" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ab593803-7c9b-47a9-8725-ceaeb107a3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17164022-b3f5-4dfe-b930-f50fe6c6ce0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad8d124b-260e-45bf-ac2b-17e26c4c6115" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17164022-b3f5-4dfe-b930-f50fe6c6ce0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6372f91-baf3-4366-b708-99505d0c1643" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad8d124b-260e-45bf-ac2b-17e26c4c6115" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c6372f91-baf3-4366-b708-99505d0c1643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_c45e035a-195d-443d-be4f-a145f69526af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad8d124b-260e-45bf-ac2b-17e26c4c6115" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_c45e035a-195d-443d-be4f-a145f69526af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aab19aac-fae8-4bbc-a4ec-f35b1dc0bd39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_c45e035a-195d-443d-be4f-a145f69526af" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aab19aac-fae8-4bbc-a4ec-f35b1dc0bd39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_6f9e4bef-c80c-4cfa-a121-92f2fdd9fd9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_c45e035a-195d-443d-be4f-a145f69526af" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_6f9e4bef-c80c-4cfa-a121-92f2fdd9fd9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_96e5d39d-7142-4995-9b0c-13fa8a0389f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_c45e035a-195d-443d-be4f-a145f69526af" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_96e5d39d-7142-4995-9b0c-13fa8a0389f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_a88eccac-f309-4dcb-a239-7895a085a830" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad8d124b-260e-45bf-ac2b-17e26c4c6115" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_a88eccac-f309-4dcb-a239-7895a085a830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_db4d123b-edbd-4cfe-a1c0-95922a183f23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a88eccac-f309-4dcb-a239-7895a085a830" xlink:to="loc_us-gaap_OperatingLeasePayments_db4d123b-edbd-4cfe-a1c0-95922a183f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_896fa87c-a8dc-4c15-b5bd-37af70517e12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a88eccac-f309-4dcb-a239-7895a085a830" xlink:to="loc_us-gaap_InterestPaidNet_896fa87c-a8dc-4c15-b5bd-37af70517e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c3c6e7de-146d-4e84-8f34-0781709b454c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ad8d124b-260e-45bf-ac2b-17e26c4c6115" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c3c6e7de-146d-4e84-8f34-0781709b454c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_26643576-a7ad-4c3f-8a85-f7d6641643c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_c3c6e7de-146d-4e84-8f34-0781709b454c" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_26643576-a7ad-4c3f-8a85-f7d6641643c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Natureofthebusinessandbasisofpresentation" xlink:type="simple" xlink:href="cccc-20240331.xsd#Natureofthebusinessandbasisofpresentation"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Natureofthebusinessandbasisofpresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_123c98b1-34d3-4178-b6f0-8c2c22299a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_cf75d2ed-02fd-4726-b48e-cf4ef410d3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_123c98b1-34d3-4178-b6f0-8c2c22299a9f" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_cf75d2ed-02fd-4726-b48e-cf4ef410d3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Summaryofsignificantaccountingpolicies" xlink:type="simple" xlink:href="cccc-20240331.xsd#Summaryofsignificantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Summaryofsignificantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_169e713e-0291-457f-81f5-cc2d2815ef98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f10064d9-0d97-4b66-9e31-cae5818be961" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_169e713e-0291-457f-81f5-cc2d2815ef98" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f10064d9-0d97-4b66-9e31-cae5818be961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Fairvaluemeasurements" xlink:type="simple" xlink:href="cccc-20240331.xsd#Fairvaluemeasurements"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Fairvaluemeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2a1b91fe-ece3-46ed-93b6-296d226cf37a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_20a106f9-99a8-4e89-be46-fe40f132162f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2a1b91fe-ece3-46ed-93b6-296d226cf37a" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_20a106f9-99a8-4e89-be46-fe40f132162f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Marketablesecurities" xlink:type="simple" xlink:href="cccc-20240331.xsd#Marketablesecurities"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Marketablesecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_b0107590-0966-4b11-bda1-2c5c6d13e3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_5ea80de6-c6c8-4eb6-8d9a-506eff28e9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_b0107590-0966-4b11-bda1-2c5c6d13e3ad" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_5ea80de6-c6c8-4eb6-8d9a-506eff28e9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Propertyandequipment" xlink:type="simple" xlink:href="cccc-20240331.xsd#Propertyandequipment"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Propertyandequipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c61cbb0e-1dae-4a1b-bd76-2d50b2023457" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c2b8306e-d20d-4359-9133-305d9e4cda93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c61cbb0e-1dae-4a1b-bd76-2d50b2023457" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_c2b8306e-d20d-4359-9133-305d9e4cda93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Leases" xlink:type="simple" xlink:href="cccc-20240331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_01656a0a-f7cc-47a0-a515-dbb941dedac0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_9cf611e9-b0d8-49d2-9056-41fc57939e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_01656a0a-f7cc-47a0-a515-dbb941dedac0" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_9cf611e9-b0d8-49d2-9056-41fc57939e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Accruedexpensesandothercurrentliabilities" xlink:type="simple" xlink:href="cccc-20240331.xsd#Accruedexpensesandothercurrentliabilities"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Accruedexpensesandothercurrentliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_ce84b571-b767-46da-a9fc-72a333e7df34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_3e9cd859-39ea-48ad-b691-79198b327432" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ce84b571-b767-46da-a9fc-72a333e7df34" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_3e9cd859-39ea-48ad-b691-79198b327432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Collaborationandlicenseagreements" xlink:type="simple" xlink:href="cccc-20240331.xsd#Collaborationandlicenseagreements"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Collaborationandlicenseagreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1dcf3c90-d082-45c1-b23c-2f702ba5a027" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_cc7ac40a-f0be-4e23-a0f3-8da11caa8770" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1dcf3c90-d082-45c1-b23c-2f702ba5a027" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_cc7ac40a-f0be-4e23-a0f3-8da11caa8770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Stockholdersequity" xlink:type="simple" xlink:href="cccc-20240331.xsd#Stockholdersequity"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Stockholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0ed84e15-a137-480f-b356-17363fb310ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c48a5e5c-b206-487e-b58f-6b3668744411" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ed84e15-a137-480f-b356-17363fb310ad" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c48a5e5c-b206-487e-b58f-6b3668744411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Stockbasedcompensation" xlink:type="simple" xlink:href="cccc-20240331.xsd#Stockbasedcompensation"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Stockbasedcompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4b60891c-65a9-4345-9144-6477a937b719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_25ee7c54-9e96-4070-8dfb-10fef9e93f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4b60891c-65a9-4345-9144-6477a937b719" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_25ee7c54-9e96-4070-8dfb-10fef9e93f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Commitmentandcontingencies" xlink:type="simple" xlink:href="cccc-20240331.xsd#Commitmentandcontingencies"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Commitmentandcontingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_154c5a0e-1cce-46fc-95e2-b2daa147b1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_15f27596-13b0-4068-aecf-d55217168d62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_154c5a0e-1cce-46fc-95e2-b2daa147b1a1" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_15f27596-13b0-4068-aecf-d55217168d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Losspershare" xlink:type="simple" xlink:href="cccc-20240331.xsd#Losspershare"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Losspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_410d1d58-4384-47f6-9889-f92246a1cde3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_d60f5beb-7144-419e-a444-2f2259118ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_410d1d58-4384-47f6-9889-f92246a1cde3" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_d60f5beb-7144-419e-a444-2f2259118ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Incometaxes" xlink:type="simple" xlink:href="cccc-20240331.xsd#Incometaxes"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Incometaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_df3a9dea-9e4e-42e2-929a-4896cea9bc28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_a00c6c44-6641-4f92-bbe0-b48f0f7d3fed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_df3a9dea-9e4e-42e2-929a-4896cea9bc28" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_a00c6c44-6641-4f92-bbe0-b48f0f7d3fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Subsequentevents" xlink:type="simple" xlink:href="cccc-20240331.xsd#Subsequentevents"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Subsequentevents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1228cf20-caf4-4767-bf53-0ff16b912346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_9663d0ec-8a1a-4b17-ae91-8c469780b38d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1228cf20-caf4-4767-bf53-0ff16b912346" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_9663d0ec-8a1a-4b17-ae91-8c469780b38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Restructuring" xlink:type="simple" xlink:href="cccc-20240331.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6653682d-ad34-4ce6-bcad-78ef57754b76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8eced3cb-8b6b-4099-a991-d4f402baaa41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6653682d-ad34-4ce6-bcad-78ef57754b76" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_8eced3cb-8b6b-4099-a991-d4f402baaa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="cccc-20240331.xsd#SummaryofsignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cb5c190d-6f9b-4d73-8c75-6822df3bd5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_fcbe7a2a-bb1c-4953-8acb-d01c41742708" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb5c190d-6f9b-4d73-8c75-6822df3bd5c3" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_fcbe7a2a-bb1c-4953-8acb-d01c41742708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_09dbeb0d-1810-4e1f-a32a-74953e992198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb5c190d-6f9b-4d73-8c75-6822df3bd5c3" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_09dbeb0d-1810-4e1f-a32a-74953e992198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_UnauditedInterimFinancialInformationPolicyPolicyTextBlock_d1e33434-2117-418e-938a-ee78ce0598cc" xlink:href="cccc-20240331.xsd#cccc_UnauditedInterimFinancialInformationPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb5c190d-6f9b-4d73-8c75-6822df3bd5c3" xlink:to="loc_cccc_UnauditedInterimFinancialInformationPolicyPolicyTextBlock_d1e33434-2117-418e-938a-ee78ce0598cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_4d4b9aeb-4a5f-475d-8a2d-8ef3b6906275" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cb5c190d-6f9b-4d73-8c75-6822df3bd5c3" xlink:to="loc_us-gaap_UseOfEstimates_4d4b9aeb-4a5f-475d-8a2d-8ef3b6906275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/FairvaluemeasurementsTables" xlink:type="simple" xlink:href="cccc-20240331.xsd#FairvaluemeasurementsTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/FairvaluemeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_18f2ae80-1035-492b-afe6-a9c4e3ed2356" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_fe20cda4-58a0-48fe-b28b-15b12f627e59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_18f2ae80-1035-492b-afe6-a9c4e3ed2356" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_fe20cda4-58a0-48fe-b28b-15b12f627e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesTables" xlink:type="simple" xlink:href="cccc-20240331.xsd#MarketablesecuritiesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_c78930ab-4fb6-4868-9ba1-0c606101963a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_a3894567-1d4a-4068-bdcf-067b5d02ca2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_c78930ab-4fb6-4868-9ba1-0c606101963a" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_a3894567-1d4a-4068-bdcf-067b5d02ca2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/PropertyandequipmentTables" xlink:type="simple" xlink:href="cccc-20240331.xsd#PropertyandequipmentTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/PropertyandequipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_56726f34-0fd3-41c4-b997-627ad0df0d62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_981cc91c-6c48-4885-967d-96e0ba72217c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_56726f34-0fd3-41c4-b997-627ad0df0d62" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_981cc91c-6c48-4885-967d-96e0ba72217c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesTables" xlink:type="simple" xlink:href="cccc-20240331.xsd#AccruedexpensesandothercurrentliabilitiesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_b7873af5-7dc7-4082-b90e-80d8b6a6837d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_ffa65564-6b67-4dc7-8d34-2f53d9c39784" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b7873af5-7dc7-4082-b90e-80d8b6a6837d" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_ffa65564-6b67-4dc7-8d34-2f53d9c39784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsTables" xlink:type="simple" xlink:href="cccc-20240331.xsd#CollaborationandlicenseagreementsTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bcd232de-3aff-4c4b-a6fa-3c8d99427ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_SummaryOfAllocationOfTotalTransactionPriceAndUnsatisfiedTransactionPriceTableTableTextBlock_0e1a24c6-13d5-43a4-b402-ecef128c6515" xlink:href="cccc-20240331.xsd#cccc_SummaryOfAllocationOfTotalTransactionPriceAndUnsatisfiedTransactionPriceTableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bcd232de-3aff-4c4b-a6fa-3c8d99427ca8" xlink:to="loc_cccc_SummaryOfAllocationOfTotalTransactionPriceAndUnsatisfiedTransactionPriceTableTableTextBlock_0e1a24c6-13d5-43a4-b402-ecef128c6515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RevenueFromCollaborationAgreementsTableTableTextBlock_e78fe47c-2cf7-4793-a627-fad28fcd1f3d" xlink:href="cccc-20240331.xsd#cccc_RevenueFromCollaborationAgreementsTableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bcd232de-3aff-4c4b-a6fa-3c8d99427ca8" xlink:to="loc_cccc_RevenueFromCollaborationAgreementsTableTableTextBlock_e78fe47c-2cf7-4793-a627-fad28fcd1f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_FinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_9ffe060e-bacc-495a-a8aa-fa67e14eb8e4" xlink:href="cccc-20240331.xsd#cccc_FinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bcd232de-3aff-4c4b-a6fa-3c8d99427ca8" xlink:to="loc_cccc_FinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_9ffe060e-bacc-495a-a8aa-fa67e14eb8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_SupplementalFinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_736a8bb9-83ff-4904-9709-fe028ed2cdba" xlink:href="cccc-20240331.xsd#cccc_SupplementalFinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bcd232de-3aff-4c4b-a6fa-3c8d99427ca8" xlink:to="loc_cccc_SupplementalFinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_736a8bb9-83ff-4904-9709-fe028ed2cdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationTables" xlink:type="simple" xlink:href="cccc-20240331.xsd#StockbasedcompensationTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_daa38cbc-6334-4018-ba9e-98699e6cf28d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6ac3d22c-b99a-4186-93cf-4d080ba8a94e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_daa38cbc-6334-4018-ba9e-98699e6cf28d" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6ac3d22c-b99a-4186-93cf-4d080ba8a94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LosspershareTables" xlink:type="simple" xlink:href="cccc-20240331.xsd#LosspershareTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d4751738-9ee5-48db-8214-e7abb5fa7a72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_56dfc18d-3422-43cb-af23-1d2f274cb790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d4751738-9ee5-48db-8214-e7abb5fa7a72" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_56dfc18d-3422-43cb-af23-1d2f274cb790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d64d6689-ab1d-4bd0-aaa7-547d21c3b670" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d4751738-9ee5-48db-8214-e7abb5fa7a72" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d64d6689-ab1d-4bd0-aaa7-547d21c3b670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/NatureofthebusinessandbasisofpresentationDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#NatureofthebusinessandbasisofpresentationDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/NatureofthebusinessandbasisofpresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56e9f7d6-9b82-478e-a462-c405baf4ff5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_834172dd-ff5f-41b0-8519-9732ca13940b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56e9f7d6-9b82-478e-a462-c405baf4ff5b" xlink:to="loc_us-gaap_ProfitLoss_834172dd-ff5f-41b0-8519-9732ca13940b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6102c02c-5f81-46db-8dec-88ae5bbe4fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56e9f7d6-9b82-478e-a462-c405baf4ff5b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6102c02c-5f81-46db-8dec-88ae5bbe4fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_d332e1b7-355c-43dc-821f-4a7b07cd44b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56e9f7d6-9b82-478e-a462-c405baf4ff5b" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_d332e1b7-355c-43dc-821f-4a7b07cd44b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/FairvaluemeasurementsDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#FairvaluemeasurementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/FairvaluemeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_567b73f1-bf71-40c8-a9c5-c5f476573b32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78479029-b6f8-4cfa-92bd-714404c16844" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_567b73f1-bf71-40c8-a9c5-c5f476573b32" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78479029-b6f8-4cfa-92bd-714404c16844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b08cdb01-2449-4931-bc7e-cb005f1c0406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78479029-b6f8-4cfa-92bd-714404c16844" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b08cdb01-2449-4931-bc7e-cb005f1c0406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_279b5848-22e6-4dbc-beeb-1ff0529a808b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b08cdb01-2449-4931-bc7e-cb005f1c0406" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_279b5848-22e6-4dbc-beeb-1ff0529a808b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f403a878-dde5-4539-b400-c7752d3e35f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_279b5848-22e6-4dbc-beeb-1ff0529a808b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f403a878-dde5-4539-b400-c7752d3e35f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9f86405e-0e06-487c-82e4-4c075acb1356" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_279b5848-22e6-4dbc-beeb-1ff0529a808b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9f86405e-0e06-487c-82e4-4c075acb1356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_49557c08-140e-4fa7-9540-929bd438e5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_279b5848-22e6-4dbc-beeb-1ff0529a808b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_49557c08-140e-4fa7-9540-929bd438e5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_38adf630-c3d0-4a24-944d-40cb363071e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78479029-b6f8-4cfa-92bd-714404c16844" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_38adf630-c3d0-4a24-944d-40cb363071e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e8fc999e-bf31-4b7c-8049-6bb2245683c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_38adf630-c3d0-4a24-944d-40cb363071e2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e8fc999e-bf31-4b7c-8049-6bb2245683c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_6b41794c-9e12-4da1-812a-5fc6e674cdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e8fc999e-bf31-4b7c-8049-6bb2245683c4" xlink:to="loc_us-gaap_MoneyMarketFundsMember_6b41794c-9e12-4da1-812a-5fc6e674cdd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e6d22312-a7e3-4fab-b61c-41d3659629be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e8fc999e-bf31-4b7c-8049-6bb2245683c4" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e6d22312-a7e3-4fab-b61c-41d3659629be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_deff670a-8ca3-455c-9fa4-d89c1dde20ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e8fc999e-bf31-4b7c-8049-6bb2245683c4" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_deff670a-8ca3-455c-9fa4-d89c1dde20ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6548de43-0fd9-4472-9af5-5a5f2e883e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78479029-b6f8-4cfa-92bd-714404c16844" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6548de43-0fd9-4472-9af5-5a5f2e883e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c8f9e584-b038-4ce6-ac00-178248fd9c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6548de43-0fd9-4472-9af5-5a5f2e883e2c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c8f9e584-b038-4ce6-ac00-178248fd9c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5ee5b9d4-79f9-4e2f-96a8-70ece75620c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c8f9e584-b038-4ce6-ac00-178248fd9c4b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5ee5b9d4-79f9-4e2f-96a8-70ece75620c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_375ded0d-f65a-49ef-9335-8b68df947d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78479029-b6f8-4cfa-92bd-714404c16844" xlink:to="loc_us-gaap_FinancialInstrumentAxis_375ded0d-f65a-49ef-9335-8b68df947d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9f2ab8f-dd5c-4d49-847f-5c7bfda0179b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_375ded0d-f65a-49ef-9335-8b68df947d0d" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9f2ab8f-dd5c-4d49-847f-5c7bfda0179b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_723a4c09-b64f-4503-950f-d073259d9569" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9f2ab8f-dd5c-4d49-847f-5c7bfda0179b" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_723a4c09-b64f-4503-950f-d073259d9569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_da3b5b1a-6e14-432d-a331-b9e52d94fd21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9f2ab8f-dd5c-4d49-847f-5c7bfda0179b" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_da3b5b1a-6e14-432d-a331-b9e52d94fd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_67dee9ed-ad2a-4bb6-9d34-c6658ce80354" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e9f2ab8f-dd5c-4d49-847f-5c7bfda0179b" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_67dee9ed-ad2a-4bb6-9d34-c6658ce80354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_45deeaf1-0c43-418c-8982-2000e9643f19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_78479029-b6f8-4cfa-92bd-714404c16844" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_45deeaf1-0c43-418c-8982-2000e9643f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7fe1d4f8-5330-4bd6-a771-7c5cc3eb110d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_45deeaf1-0c43-418c-8982-2000e9643f19" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7fe1d4f8-5330-4bd6-a771-7c5cc3eb110d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_132d9770-460a-45fb-9968-49b4f5872c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_45deeaf1-0c43-418c-8982-2000e9643f19" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_132d9770-460a-45fb-9968-49b4f5872c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_aa4a2a0d-4f72-4f86-aabd-d68dcf17949a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_45deeaf1-0c43-418c-8982-2000e9643f19" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_aa4a2a0d-4f72-4f86-aabd-d68dcf17949a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#MarketablesecuritiesSummaryofmarketablesecuritiesDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_0074e6ee-5996-4a67-9ae3-be0861b36635" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d72992df-533d-4618-a80d-c2fe70140217" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_0074e6ee-5996-4a67-9ae3-be0861b36635" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d72992df-533d-4618-a80d-c2fe70140217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_21d9ca55-35ad-4446-9a75-22af607e6eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d72992df-533d-4618-a80d-c2fe70140217" xlink:to="loc_us-gaap_FinancialInstrumentAxis_21d9ca55-35ad-4446-9a75-22af607e6eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_26c054f1-29ca-4301-81a9-e75b858dc546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_21d9ca55-35ad-4446-9a75-22af607e6eb5" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_26c054f1-29ca-4301-81a9-e75b858dc546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_d6f63bf7-5a46-4cc0-9b49-6afd0ec453a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_26c054f1-29ca-4301-81a9-e75b858dc546" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_d6f63bf7-5a46-4cc0-9b49-6afd0ec453a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ea7967f7-1664-48f6-ac33-9f19da3534e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_26c054f1-29ca-4301-81a9-e75b858dc546" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ea7967f7-1664-48f6-ac33-9f19da3534e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_1789e71f-093e-4163-bec1-bffa449af801" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_26c054f1-29ca-4301-81a9-e75b858dc546" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_1789e71f-093e-4163-bec1-bffa449af801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0436c25a-9dcf-493f-a72c-8336b3f3a32f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_d72992df-533d-4618-a80d-c2fe70140217" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0436c25a-9dcf-493f-a72c-8336b3f3a32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_e2416226-ed1d-4f95-bbaa-9d4fa19d7fc4" xlink:href="cccc-20240331.xsd#cccc_DebtSecuritiesAvailableForSaleCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0436c25a-9dcf-493f-a72c-8336b3f3a32f" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_e2416226-ed1d-4f95-bbaa-9d4fa19d7fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_6016742a-f412-40f2-9480-3590ae122f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_e2416226-ed1d-4f95-bbaa-9d4fa19d7fc4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_6016742a-f412-40f2-9480-3590ae122f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_f053c9fe-546e-4149-836f-35180e798d5c" xlink:href="cccc-20240331.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_e2416226-ed1d-4f95-bbaa-9d4fa19d7fc4" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_f053c9fe-546e-4149-836f-35180e798d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_54aff0df-a79c-4fb7-85e4-95f2ec77074b" xlink:href="cccc-20240331.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_e2416226-ed1d-4f95-bbaa-9d4fa19d7fc4" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_54aff0df-a79c-4fb7-85e4-95f2ec77074b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_f298f05a-f2cb-4f4d-8e98-cb17207cf3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_e2416226-ed1d-4f95-bbaa-9d4fa19d7fc4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_f298f05a-f2cb-4f4d-8e98-cb17207cf3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_6ec93b3c-e4d3-4a61-9422-164dc1e589b9" xlink:href="cccc-20240331.xsd#cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0436c25a-9dcf-493f-a72c-8336b3f3a32f" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_6ec93b3c-e4d3-4a61-9422-164dc1e589b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_acf7df76-b49a-4c86-a4bf-2c4d45985b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_6ec93b3c-e4d3-4a61-9422-164dc1e589b9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_acf7df76-b49a-4c86-a4bf-2c4d45985b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent_718944af-8618-4b3f-b0ab-4e684f9327e1" xlink:href="cccc-20240331.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_6ec93b3c-e4d3-4a61-9422-164dc1e589b9" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent_718944af-8618-4b3f-b0ab-4e684f9327e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent_0432f4e9-d7d2-4503-adcc-04dfe9adc6d9" xlink:href="cccc-20240331.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_6ec93b3c-e4d3-4a61-9422-164dc1e589b9" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent_0432f4e9-d7d2-4503-adcc-04dfe9adc6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_034ef2cc-e276-4042-aba6-ce6f7eb3c8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_6ec93b3c-e4d3-4a61-9422-164dc1e589b9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_034ef2cc-e276-4042-aba6-ce6f7eb3c8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_a168da19-65cc-42aa-beba-b2cabc973091" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0436c25a-9dcf-493f-a72c-8336b3f3a32f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_a168da19-65cc-42aa-beba-b2cabc973091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3d967fb2-85cc-42e6-963b-af2748c5803e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0436c25a-9dcf-493f-a72c-8336b3f3a32f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3d967fb2-85cc-42e6-963b-af2748c5803e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1b7ab177-8c6a-4044-b0fa-6caef67d0faf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0436c25a-9dcf-493f-a72c-8336b3f3a32f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1b7ab177-8c6a-4044-b0fa-6caef67d0faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_1412fec8-80b8-4a26-ad09-570139099c79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_0436c25a-9dcf-493f-a72c-8336b3f3a32f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_1412fec8-80b8-4a26-ad09-570139099c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesNarrativeDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#MarketablesecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_358614f0-99a3-4473-851b-d12dac0c12b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_cd443d53-a5d8-4c59-ba22-636ed40d0385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_358614f0-99a3-4473-851b-d12dac0c12b0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_cd443d53-a5d8-4c59-ba22-636ed40d0385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/PropertyandequipmentDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#PropertyandequipmentDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/PropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ccba24e9-38a2-485d-8d54-04be25bdd395" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4e972b79-2ada-4649-bef9-49a493aa77cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ccba24e9-38a2-485d-8d54-04be25bdd395" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4e972b79-2ada-4649-bef9-49a493aa77cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2c7e6fb7-a05b-469a-a497-34228ac89ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4e972b79-2ada-4649-bef9-49a493aa77cb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2c7e6fb7-a05b-469a-a497-34228ac89ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_108374cd-022a-4556-b81a-ed6b2bba3f32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2c7e6fb7-a05b-469a-a497-34228ac89ae1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_108374cd-022a-4556-b81a-ed6b2bba3f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LaboratoryEquipmentMember_47a5306b-a1cc-4780-bb72-b45a082bd187" xlink:href="cccc-20240331.xsd#cccc_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_108374cd-022a-4556-b81a-ed6b2bba3f32" xlink:to="loc_cccc_LaboratoryEquipmentMember_47a5306b-a1cc-4780-bb72-b45a082bd187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_2ae6d06d-74cc-4ef5-a6c0-b26f9300ae83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_108374cd-022a-4556-b81a-ed6b2bba3f32" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_2ae6d06d-74cc-4ef5-a6c0-b26f9300ae83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_42f2d8c5-5c06-4e7b-b7a5-19484279b1be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_108374cd-022a-4556-b81a-ed6b2bba3f32" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_42f2d8c5-5c06-4e7b-b7a5-19484279b1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_2fde70bf-1b08-449d-9fef-3b0093badcea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_108374cd-022a-4556-b81a-ed6b2bba3f32" xlink:to="loc_us-gaap_OfficeEquipmentMember_2fde70bf-1b08-449d-9fef-3b0093badcea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_7f905279-873b-4ffd-ae4d-5ce5cd3e47a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_108374cd-022a-4556-b81a-ed6b2bba3f32" xlink:to="loc_us-gaap_ComputerEquipmentMember_7f905279-873b-4ffd-ae4d-5ce5cd3e47a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cbb11cd-c235-476a-abc8-56cfb61d8f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4e972b79-2ada-4649-bef9-49a493aa77cb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cbb11cd-c235-476a-abc8-56cfb61d8f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_45a2bdef-02ea-48fc-894c-f2960b3d7a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cbb11cd-c235-476a-abc8-56cfb61d8f9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_45a2bdef-02ea-48fc-894c-f2960b3d7a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8c95aff6-0315-4c37-bb45-412870b9a80c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cbb11cd-c235-476a-abc8-56cfb61d8f9e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8c95aff6-0315-4c37-bb45-412870b9a80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5371a8a7-e40d-4012-baea-6f35a2180c79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cbb11cd-c235-476a-abc8-56cfb61d8f9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5371a8a7-e40d-4012-baea-6f35a2180c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_c36ceaf7-7f1c-42fb-8ddc-0bc1662c343a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9cbb11cd-c235-476a-abc8-56cfb61d8f9e" xlink:to="loc_us-gaap_Depreciation_c36ceaf7-7f1c-42fb-8ddc-0bc1662c343a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#AccruedexpensesandothercurrentliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_e343f61e-a559-409b-9d49-f4cfd1fac36c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_624ba451-d59d-49ec-b7da-af72477bfe1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e343f61e-a559-409b-9d49-f4cfd1fac36c" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_624ba451-d59d-49ec-b7da-af72477bfe1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AccruedResearchAndDevelopmentCurrent_ef62dafb-ad3e-480e-a57b-5aa7e91dbf06" xlink:href="cccc-20240331.xsd#cccc_AccruedResearchAndDevelopmentCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_624ba451-d59d-49ec-b7da-af72477bfe1a" xlink:to="loc_cccc_AccruedResearchAndDevelopmentCurrent_ef62dafb-ad3e-480e-a57b-5aa7e91dbf06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_bd67e895-db20-4785-903c-a9876c3dbe39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_624ba451-d59d-49ec-b7da-af72477bfe1a" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_bd67e895-db20-4785-903c-a9876c3dbe39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1b88cc2d-04ec-45a0-938f-404f8655dc99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_624ba451-d59d-49ec-b7da-af72477bfe1a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1b88cc2d-04ec-45a0-938f-404f8655dc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_435e12a0-da5c-4a70-a54e-4255de39c156" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_624ba451-d59d-49ec-b7da-af72477bfe1a" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_435e12a0-da5c-4a70-a54e-4255de39c156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsNarrativeDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#CollaborationandlicenseagreementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a1149b1b-65f7-4919-bad4-0a5bc669048e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_20d28a1c-a214-4041-9839-d803e614140b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a1149b1b-65f7-4919-bad4-0a5bc669048e" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_20d28a1c-a214-4041-9839-d803e614140b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f4eed607-c70f-4691-871f-2193c238feb7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_20d28a1c-a214-4041-9839-d803e614140b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f4eed607-c70f-4691-871f-2193c238feb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5a067e6a-972e-4588-94de-f270db8501d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f4eed607-c70f-4691-871f-2193c238feb7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5a067e6a-972e-4588-94de-f270db8501d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_058f7d83-e24c-499f-a116-4cb6c0d65c48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_5a067e6a-972e-4588-94de-f270db8501d3" xlink:to="loc_us-gaap_SubsequentEventMember_058f7d83-e24c-499f-a116-4cb6c0d65c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_0bff0be4-e8fe-48b2-9356-1cb4e66db9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_20d28a1c-a214-4041-9839-d803e614140b" xlink:to="loc_us-gaap_TypeOfArrangementAxis_0bff0be4-e8fe-48b2-9356-1cb4e66db9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a6d8c45-8755-43ab-b6a9-a3083baed2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_0bff0be4-e8fe-48b2-9356-1cb4e66db9b0" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a6d8c45-8755-43ab-b6a9-a3083baed2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MKDGAgreementMember_7ffcde1d-5917-49a5-a999-c4db0d83b54a" xlink:href="cccc-20240331.xsd#cccc_MKDGAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a6d8c45-8755-43ab-b6a9-a3083baed2a0" xlink:to="loc_cccc_MKDGAgreementMember_7ffcde1d-5917-49a5-a999-c4db0d83b54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MerckAgreementMember_b944b977-6735-4359-8b61-227325dbeebc" xlink:href="cccc-20240331.xsd#cccc_MerckAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a6d8c45-8755-43ab-b6a9-a3083baed2a0" xlink:to="loc_cccc_MerckAgreementMember_b944b977-6735-4359-8b61-227325dbeebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BettaAgreementMember_473e6b5a-2f79-493e-807c-489ad8a41b05" xlink:href="cccc-20240331.xsd#cccc_BettaAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a6d8c45-8755-43ab-b6a9-a3083baed2a0" xlink:to="loc_cccc_BettaAgreementMember_473e6b5a-2f79-493e-807c-489ad8a41b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RestatedRocheAgreementMember_b9dd0291-7029-489b-9e38-1f45c92408e6" xlink:href="cccc-20240331.xsd#cccc_RestatedRocheAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a6d8c45-8755-43ab-b6a9-a3083baed2a0" xlink:to="loc_cccc_RestatedRocheAgreementMember_b9dd0291-7029-489b-9e38-1f45c92408e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BiogenResearchAndLicenseAgreementMember_d0829048-4d14-475f-9398-f014e0b606e3" xlink:href="cccc-20240331.xsd#cccc_BiogenResearchAndLicenseAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a6d8c45-8755-43ab-b6a9-a3083baed2a0" xlink:to="loc_cccc_BiogenResearchAndLicenseAgreementMember_d0829048-4d14-475f-9398-f014e0b606e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CalicoLicenseAgreementMember_c4875b36-dc9d-4c96-9497-d61be8b2863a" xlink:href="cccc-20240331.xsd#cccc_CalicoLicenseAgreementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a6d8c45-8755-43ab-b6a9-a3083baed2a0" xlink:to="loc_cccc_CalicoLicenseAgreementMember_c4875b36-dc9d-4c96-9497-d61be8b2863a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RestatedRocheAgreementAndBiogenLicenseAgreementMember_4715cdd3-2257-401a-8a1b-b7200a97546e" xlink:href="cccc-20240331.xsd#cccc_RestatedRocheAgreementAndBiogenLicenseAgreementMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1a6d8c45-8755-43ab-b6a9-a3083baed2a0" xlink:to="loc_cccc_RestatedRocheAgreementAndBiogenLicenseAgreementMember_4715cdd3-2257-401a-8a1b-b7200a97546e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6e0514bf-5b48-4152-b401-e1a4e332440a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_20d28a1c-a214-4041-9839-d803e614140b" xlink:to="loc_srt_ProductOrServiceAxis_6e0514bf-5b48-4152-b401-e1a4e332440a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_548bbe0f-879b-46b5-a202-151248164b58" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6e0514bf-5b48-4152-b401-e1a4e332440a" xlink:to="loc_srt_ProductsAndServicesDomain_548bbe0f-879b-46b5-a202-151248164b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LeadSeriesIdentificationAchievementMember_f782a4d2-8a53-48b9-8cdc-42b7533be4a2" xlink:href="cccc-20240331.xsd#cccc_LeadSeriesIdentificationAchievementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_548bbe0f-879b-46b5-a202-151248164b58" xlink:to="loc_cccc_LeadSeriesIdentificationAchievementMember_f782a4d2-8a53-48b9-8cdc-42b7533be4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3c5f971b-ac07-4ad8-8ba4-bc3569cab427" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_20d28a1c-a214-4041-9839-d803e614140b" xlink:to="loc_srt_RangeAxis_3c5f971b-ac07-4ad8-8ba4-bc3569cab427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e51ade33-9858-4dbc-ac0e-7e241155f61d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3c5f971b-ac07-4ad8-8ba4-bc3569cab427" xlink:to="loc_srt_RangeMember_e51ade33-9858-4dbc-ac0e-7e241155f61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4c4a2c44-21fd-4cf3-b2e7-f444794b7e73" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e51ade33-9858-4dbc-ac0e-7e241155f61d" xlink:to="loc_srt_MinimumMember_4c4a2c44-21fd-4cf3-b2e7-f444794b7e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ef8b903a-78af-4615-ac9a-f23de2ae91b9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e51ade33-9858-4dbc-ac0e-7e241155f61d" xlink:to="loc_srt_MaximumMember_ef8b903a-78af-4615-ac9a-f23de2ae91b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2a63a962-a0b7-4af8-968d-df6216b45d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_20d28a1c-a214-4041-9839-d803e614140b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2a63a962-a0b7-4af8-968d-df6216b45d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb17ddd-86f6-49ec-8104-28649070cf7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2a63a962-a0b7-4af8-968d-df6216b45d0f" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb17ddd-86f6-49ec-8104-28649070cf7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DiscoveryRegulatoryAndCommercialMilestonesMember_10495b77-1b29-4e4d-bd7e-9a02624b1b2b" xlink:href="cccc-20240331.xsd#cccc_DiscoveryRegulatoryAndCommercialMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb17ddd-86f6-49ec-8104-28649070cf7e" xlink:to="loc_cccc_DiscoveryRegulatoryAndCommercialMilestonesMember_10495b77-1b29-4e4d-bd7e-9a02624b1b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentMilestonesMember_3e6e7d8c-4217-4c45-a0dd-a12073206368" xlink:href="cccc-20240331.xsd#cccc_ResearchAndDevelopmentMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb17ddd-86f6-49ec-8104-28649070cf7e" xlink:to="loc_cccc_ResearchAndDevelopmentMilestonesMember_3e6e7d8c-4217-4c45-a0dd-a12073206368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchDevelopmentAndCommercialMilestonePaymentsMember_52af3177-a9b4-4e95-94f6-88081c03fcc6" xlink:href="cccc-20240331.xsd#cccc_ResearchDevelopmentAndCommercialMilestonePaymentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb17ddd-86f6-49ec-8104-28649070cf7e" xlink:to="loc_cccc_ResearchDevelopmentAndCommercialMilestonePaymentsMember_52af3177-a9b4-4e95-94f6-88081c03fcc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OneTimeSalesBasedPaymentsMember_6bebfe3f-51da-41fe-80b0-3f4b4415d775" xlink:href="cccc-20240331.xsd#cccc_OneTimeSalesBasedPaymentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb17ddd-86f6-49ec-8104-28649070cf7e" xlink:to="loc_cccc_OneTimeSalesBasedPaymentsMember_6bebfe3f-51da-41fe-80b0-3f4b4415d775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentServicesMember_5cbecf5d-54fd-4048-8b08-d7c9a2ecc674" xlink:href="cccc-20240331.xsd#cccc_ResearchAndDevelopmentServicesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb17ddd-86f6-49ec-8104-28649070cf7e" xlink:to="loc_cccc_ResearchAndDevelopmentServicesMember_5cbecf5d-54fd-4048-8b08-d7c9a2ecc674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_PotentialResearchDevelopmentAndCommercialMilestonePaymentsMember_932724bf-d6e5-49de-9cf2-ebd72650c3c7" xlink:href="cccc-20240331.xsd#cccc_PotentialResearchDevelopmentAndCommercialMilestonePaymentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb17ddd-86f6-49ec-8104-28649070cf7e" xlink:to="loc_cccc_PotentialResearchDevelopmentAndCommercialMilestonePaymentsMember_932724bf-d6e5-49de-9cf2-ebd72650c3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DrugApplicationApprovalMember_1ef996c8-da3e-4410-a84b-17f7f642c2b2" xlink:href="cccc-20240331.xsd#cccc_DrugApplicationApprovalMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb17ddd-86f6-49ec-8104-28649070cf7e" xlink:to="loc_cccc_DrugApplicationApprovalMember_1ef996c8-da3e-4410-a84b-17f7f642c2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MKDGAgreementMember_24eb118c-cb47-4871-a846-1d150fbc6522" xlink:href="cccc-20240331.xsd#cccc_MKDGAgreementMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb17ddd-86f6-49ec-8104-28649070cf7e" xlink:to="loc_cccc_MKDGAgreementMember_24eb118c-cb47-4871-a846-1d150fbc6522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_2ae944f6-ed35-4f19-bc3a-454fc7db3671" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_20d28a1c-a214-4041-9839-d803e614140b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_2ae944f6-ed35-4f19-bc3a-454fc7db3671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_c90ffa5d-1ed0-4b81-a5e5-3f2457d7737f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_2ae944f6-ed35-4f19-bc3a-454fc7db3671" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_c90ffa5d-1ed0-4b81-a5e5-3f2457d7737f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_4d8b5da5-cb98-4318-89c6-de527e6e11ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_c90ffa5d-1ed0-4b81-a5e5-3f2457d7737f" xlink:to="loc_us-gaap_ForeignCountryMember_4d8b5da5-cb98-4318-89c6-de527e6e11ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_20d28a1c-a214-4041-9839-d803e614140b" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_UpfrontPayment_7769163b-c074-4a2a-b1ce-d920e48e6083" xlink:href="cccc-20240331.xsd#cccc_UpfrontPayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_UpfrontPayment_7769163b-c074-4a2a-b1ce-d920e48e6083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractsReceivableClaimsAndUncertainAmounts_5a22ba8e-24b6-4acf-990e-f60c8b7c3c89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractsReceivableClaimsAndUncertainAmounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_us-gaap_ContractsReceivableClaimsAndUncertainAmounts_5a22ba8e-24b6-4acf-990e-f60c8b7c3c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NoticePeriodForTerminationOfAgreement_19b0b544-550c-4904-acb6-6bea567c41fd" xlink:href="cccc-20240331.xsd#cccc_NoticePeriodForTerminationOfAgreement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_NoticePeriodForTerminationOfAgreement_19b0b544-550c-4904-acb6-6bea567c41fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfPerformanceObligations_aced0b3d-1cc7-4d9e-91cd-d00c1ad192c4" xlink:href="cccc-20240331.xsd#cccc_NumberOfPerformanceObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_NumberOfPerformanceObligations_aced0b3d-1cc7-4d9e-91cd-d00c1ad192c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfPotentialResearchAndDevelopmentTargets_aac85bf3-6952-48fb-b020-91feca3b2e6d" xlink:href="cccc-20240331.xsd#cccc_NumberOfPotentialResearchAndDevelopmentTargets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_NumberOfPotentialResearchAndDevelopmentTargets_aac85bf3-6952-48fb-b020-91feca3b2e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_43ee8904-7d81-410d-9b33-b698e6868dba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_us-gaap_ContractWithCustomerLiability_43ee8904-7d81-410d-9b33-b698e6868dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OptionToIncludeNumberOfAdditionalTargets_0a719c4f-f492-48ce-aba6-245429392156" xlink:href="cccc-20240331.xsd#cccc_OptionToIncludeNumberOfAdditionalTargets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_OptionToIncludeNumberOfAdditionalTargets_0a719c4f-f492-48ce-aba6-245429392156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CollaborativeArrangementPotentialProceedsFromCollaboration_18604cc1-f4cb-437f-9cb2-0ffd28d267a6" xlink:href="cccc-20240331.xsd#cccc_CollaborativeArrangementPotentialProceedsFromCollaboration"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_CollaborativeArrangementPotentialProceedsFromCollaboration_18604cc1-f4cb-437f-9cb2-0ffd28d267a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_aab23bb1-963a-4698-8692-7a9bf1b655f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_aab23bb1-963a-4698-8692-7a9bf1b655f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1e51693f-d713-4b7d-aae0-b155eb0061f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1e51693f-d713-4b7d-aae0-b155eb0061f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_dfce4f0c-5861-4cbf-9949-ed23ffea9562" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_us-gaap_SharePrice_dfce4f0c-5861-4cbf-9949-ed23ffea9562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfTargets_ef77aa6e-de97-4379-b157-bd41b6e3b5fd" xlink:href="cccc-20240331.xsd#cccc_NumberOfTargets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_NumberOfTargets_ef77aa6e-de97-4379-b157-bd41b6e3b5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TransactionPriceFromClosingOfTheStockPurchaseAgreement_c86ed718-06a9-442a-8da4-d800d1aaa1b2" xlink:href="cccc-20240331.xsd#cccc_TransactionPriceFromClosingOfTheStockPurchaseAgreement"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_TransactionPriceFromClosingOfTheStockPurchaseAgreement_c86ed718-06a9-442a-8da4-d800d1aaa1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CollaborativeArrangementRegulatoryMilestoneAchieved_bc1a4a3f-34fb-4efc-bd70-0b795f5b36b2" xlink:href="cccc-20240331.xsd#cccc_CollaborativeArrangementRegulatoryMilestoneAchieved"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_CollaborativeArrangementRegulatoryMilestoneAchieved_bc1a4a3f-34fb-4efc-bd70-0b795f5b36b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_PaymentsForTaxWithholdings_e267a2a1-7d25-44c0-8f36-9adca3896bc5" xlink:href="cccc-20240331.xsd#cccc_PaymentsForTaxWithholdings"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_PaymentsForTaxWithholdings_e267a2a1-7d25-44c0-8f36-9adca3896bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AdditionalUpfrontConsideration_cb52ee1c-9cea-4793-9b67-03e8c6218bbd" xlink:href="cccc-20240331.xsd#cccc_AdditionalUpfrontConsideration"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_AdditionalUpfrontConsideration_cb52ee1c-9cea-4793-9b67-03e8c6218bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfPotentialTargets_3297a169-c0ab-4185-941b-e99b914c386c" xlink:href="cccc-20240331.xsd#cccc_NumberOfPotentialTargets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_NumberOfPotentialTargets_3297a169-c0ab-4185-941b-e99b914c386c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AnnualResearchPlanPaymentsReceivables_74ca778f-6f18-4274-98d6-b7b59f2226e0" xlink:href="cccc-20240331.xsd#cccc_AnnualResearchPlanPaymentsReceivables"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_AnnualResearchPlanPaymentsReceivables_74ca778f-6f18-4274-98d6-b7b59f2226e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_UpfrontFees_c5234d37-311c-4551-83d4-844868792964" xlink:href="cccc-20240331.xsd#cccc_UpfrontFees"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_UpfrontFees_c5234d37-311c-4551-83d4-844868792964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OptionExerciseFee_96cda652-d034-45e7-a2d8-869405b545f7" xlink:href="cccc-20240331.xsd#cccc_OptionExerciseFee"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_OptionExerciseFee_96cda652-d034-45e7-a2d8-869405b545f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5fd7f508-9c29-4a2a-93fa-c12091500d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5fd7f508-9c29-4a2a-93fa-c12091500d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfTargetedProteinDegradation_68f73e49-aa54-47cd-aed7-1abb763cc933" xlink:href="cccc-20240331.xsd#cccc_NumberOfTargetedProteinDegradation"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_NumberOfTargetedProteinDegradation_68f73e49-aa54-47cd-aed7-1abb763cc933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentAgreementPeriod_7e13ff77-5ae2-4a75-89bd-25740f016259" xlink:href="cccc-20240331.xsd#cccc_ResearchAndDevelopmentAgreementPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_ResearchAndDevelopmentAgreementPeriod_7e13ff77-5ae2-4a75-89bd-25740f016259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NonRefundableUpfrontPayment_891129f7-f654-4ea3-a14c-2634bc51dee7" xlink:href="cccc-20240331.xsd#cccc_NonRefundableUpfrontPayment"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_NonRefundableUpfrontPayment_891129f7-f654-4ea3-a14c-2634bc51dee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_e688dad2-3e0b-4182-b0c4-459a4b91be6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_us-gaap_ProceedsFromCollaborators_e688dad2-3e0b-4182-b0c4-459a4b91be6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b17a0896-69b8-4cf0-a462-ba1dd6ab207b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b17a0896-69b8-4cf0-a462-ba1dd6ab207b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_074cb933-9903-4dae-a9d0-b935824cd4d0" xlink:href="cccc-20240331.xsd#cccc_TransactionPriceAllocatedToPerformanceObligation"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_074cb933-9903-4dae-a9d0-b935824cd4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchTerm_bfdc2be5-3dab-4cf4-977b-9a81f1c6ffd7" xlink:href="cccc-20240331.xsd#cccc_ResearchTerm"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_ResearchTerm_bfdc2be5-3dab-4cf4-977b-9a81f1c6ffd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchExtendedTerm_b849a4a1-25f1-44c0-b3e6-ceff3293c8a8" xlink:href="cccc-20240331.xsd#cccc_ResearchExtendedTerm"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_ResearchExtendedTerm_b849a4a1-25f1-44c0-b3e6-ceff3293c8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AmountPayableForExtendResearchTermOption_7ac21bf6-1678-46b1-8b7d-13ee41df9abf" xlink:href="cccc-20240331.xsd#cccc_AmountPayableForExtendResearchTermOption"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_AmountPayableForExtendResearchTermOption_7ac21bf6-1678-46b1-8b7d-13ee41df9abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AnnualPayments_7accb56b-1939-47d0-92bf-2dbcbc310381" xlink:href="cccc-20240331.xsd#cccc_AnnualPayments"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_AnnualPayments_7accb56b-1939-47d0-92bf-2dbcbc310381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_StockRepurchaseProgramPremiumPercentage_a2bcfddc-8b30-4066-b20b-478cf41ac823" xlink:href="cccc-20240331.xsd#cccc_StockRepurchaseProgramPremiumPercentage"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_StockRepurchaseProgramPremiumPercentage_a2bcfddc-8b30-4066-b20b-478cf41ac823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfPerformanceObligation_f5a5b028-75dc-4354-87b6-3d69f5b2c120" xlink:href="cccc-20240331.xsd#cccc_NumberOfPerformanceObligation"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_61ec4e6f-7de3-4ce1-ae75-5afe0123fa42" xlink:to="loc_cccc_NumberOfPerformanceObligation_f5a5b028-75dc-4354-87b6-3d69f5b2c120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsSummaryofallocationoftransactionpriceDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#CollaborationandlicenseagreementsSummaryofallocationoftransactionpriceDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsSummaryofallocationoftransactionpriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f5627e9f-b5d3-4d8c-bde7-13c56d9ab09d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c1d876e9-e859-456a-bc2c-20cb8ccfcc41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f5627e9f-b5d3-4d8c-bde7-13c56d9ab09d" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c1d876e9-e859-456a-bc2c-20cb8ccfcc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b9929a3e-7153-48c6-8f3d-49e1d592fc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c1d876e9-e859-456a-bc2c-20cb8ccfcc41" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b9929a3e-7153-48c6-8f3d-49e1d592fc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2db7cf58-b134-4ab4-8ae5-c7f5be29877f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b9929a3e-7153-48c6-8f3d-49e1d592fc6d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2db7cf58-b134-4ab4-8ae5-c7f5be29877f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentTargetsMember_53384d91-68e1-46dc-a4a9-074da446b6dc" xlink:href="cccc-20240331.xsd#cccc_ResearchAndDevelopmentTargetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2db7cf58-b134-4ab4-8ae5-c7f5be29877f" xlink:to="loc_cccc_ResearchAndDevelopmentTargetsMember_53384d91-68e1-46dc-a4a9-074da446b6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OptionRightsMember_f92111c1-75f3-407d-892b-f280627edf5f" xlink:href="cccc-20240331.xsd#cccc_OptionRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2db7cf58-b134-4ab4-8ae5-c7f5be29877f" xlink:to="loc_cccc_OptionRightsMember_f92111c1-75f3-407d-892b-f280627edf5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_355f9f80-7cef-470b-b7e5-feabd7d7bf98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_c1d876e9-e859-456a-bc2c-20cb8ccfcc41" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_355f9f80-7cef-470b-b7e5-feabd7d7bf98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_9ea1093a-613c-46d7-a661-a6f3a911dee9" xlink:href="cccc-20240331.xsd#cccc_TransactionPriceAllocatedToPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_355f9f80-7cef-470b-b7e5-feabd7d7bf98" xlink:to="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_9ea1093a-613c-46d7-a661-a6f3a911dee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TransactionPriceUnsatisfiedToPerformanceObligation_2074b143-5467-4b24-b117-7bb13db30973" xlink:href="cccc-20240331.xsd#cccc_TransactionPriceUnsatisfiedToPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_355f9f80-7cef-470b-b7e5-feabd7d7bf98" xlink:to="loc_cccc_TransactionPriceUnsatisfiedToPerformanceObligation_2074b143-5467-4b24-b117-7bb13db30973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofrevenuefromcollaborationagreementsDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#CollaborationandlicenseagreementsScheduleofrevenuefromcollaborationagreementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofrevenuefromcollaborationagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a9568535-036b-4ad8-94c1-6ce32a55c9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7e039e7c-0c0d-4a90-bd02-e9f064482b12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a9568535-036b-4ad8-94c1-6ce32a55c9a4" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7e039e7c-0c0d-4a90-bd02-e9f064482b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7f485243-6ee6-4d9b-b2e2-971cee31e604" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7e039e7c-0c0d-4a90-bd02-e9f064482b12" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7f485243-6ee6-4d9b-b2e2-971cee31e604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2dc9269-c844-40b1-b907-db847f6e4072" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7f485243-6ee6-4d9b-b2e2-971cee31e604" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2dc9269-c844-40b1-b907-db847f6e4072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MKDGAgreementMember_ec4e1b0a-d564-48ac-9d13-5ec41c61030d" xlink:href="cccc-20240331.xsd#cccc_MKDGAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2dc9269-c844-40b1-b907-db847f6e4072" xlink:to="loc_cccc_MKDGAgreementMember_ec4e1b0a-d564-48ac-9d13-5ec41c61030d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MerckAgreementMember_2da060ac-1234-4e83-b54d-30fb90a96fd2" xlink:href="cccc-20240331.xsd#cccc_MerckAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2dc9269-c844-40b1-b907-db847f6e4072" xlink:to="loc_cccc_MerckAgreementMember_2da060ac-1234-4e83-b54d-30fb90a96fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RocheAgreementMember_62578350-38bb-4f26-8ba0-01f4c770e40b" xlink:href="cccc-20240331.xsd#cccc_RocheAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2dc9269-c844-40b1-b907-db847f6e4072" xlink:to="loc_cccc_RocheAgreementMember_62578350-38bb-4f26-8ba0-01f4c770e40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BiogenAgreementMember_1696049d-339b-4a39-8a7a-8c74e0ec3e1e" xlink:href="cccc-20240331.xsd#cccc_BiogenAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2dc9269-c844-40b1-b907-db847f6e4072" xlink:to="loc_cccc_BiogenAgreementMember_1696049d-339b-4a39-8a7a-8c74e0ec3e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CalicoAgreementMember_4d7effab-b388-45f5-8bae-d22927b90803" xlink:href="cccc-20240331.xsd#cccc_CalicoAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2dc9269-c844-40b1-b907-db847f6e4072" xlink:to="loc_cccc_CalicoAgreementMember_4d7effab-b388-45f5-8bae-d22927b90803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_703d7303-ddb5-47f6-a8fd-a3a292fa898a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_7e039e7c-0c0d-4a90-bd02-e9f064482b12" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_703d7303-ddb5-47f6-a8fd-a3a292fa898a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2e08dfd8-65e7-41b7-9347-d137ec61dba7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_703d7303-ddb5-47f6-a8fd-a3a292fa898a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2e08dfd8-65e7-41b7-9347-d137ec61dba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0eebc279-80a7-4a4a-8043-1eb38222d97e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_346b0d11-45ed-4a5b-95b0-75f743ab9c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0eebc279-80a7-4a4a-8043-1eb38222d97e" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_346b0d11-45ed-4a5b-95b0-75f743ab9c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_dce3c393-f8b8-4b17-bad8-db0a33fc85d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_346b0d11-45ed-4a5b-95b0-75f743ab9c8a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_dce3c393-f8b8-4b17-bad8-db0a33fc85d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6e44a3c3-6948-41cf-9e96-998acbb20d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_dce3c393-f8b8-4b17-bad8-db0a33fc85d5" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6e44a3c3-6948-41cf-9e96-998acbb20d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MKDGAgreementMember_a234590a-926b-4028-b15b-46a501e4526b" xlink:href="cccc-20240331.xsd#cccc_MKDGAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6e44a3c3-6948-41cf-9e96-998acbb20d5c" xlink:to="loc_cccc_MKDGAgreementMember_a234590a-926b-4028-b15b-46a501e4526b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MerckAgreementMember_2ce9aa06-c752-46be-85e4-30d9cbbcea3d" xlink:href="cccc-20240331.xsd#cccc_MerckAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6e44a3c3-6948-41cf-9e96-998acbb20d5c" xlink:to="loc_cccc_MerckAgreementMember_2ce9aa06-c752-46be-85e4-30d9cbbcea3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BettaAgreementMember_51e88e7e-88ae-4276-932f-2c6ff86ef7c3" xlink:href="cccc-20240331.xsd#cccc_BettaAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6e44a3c3-6948-41cf-9e96-998acbb20d5c" xlink:to="loc_cccc_BettaAgreementMember_51e88e7e-88ae-4276-932f-2c6ff86ef7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RocheAgreementMember_f4bf034f-25ff-48c1-bdc9-9fb42f214668" xlink:href="cccc-20240331.xsd#cccc_RocheAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6e44a3c3-6948-41cf-9e96-998acbb20d5c" xlink:to="loc_cccc_RocheAgreementMember_f4bf034f-25ff-48c1-bdc9-9fb42f214668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BiogenAgreementMember_78f17435-0e11-42a2-86ee-35af57f09333" xlink:href="cccc-20240331.xsd#cccc_BiogenAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6e44a3c3-6948-41cf-9e96-998acbb20d5c" xlink:to="loc_cccc_BiogenAgreementMember_78f17435-0e11-42a2-86ee-35af57f09333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9db8b17-88bf-4342-901a-5cb7f6f2615e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_346b0d11-45ed-4a5b-95b0-75f743ab9c8a" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9db8b17-88bf-4342-901a-5cb7f6f2615e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_f6e906b2-1797-4046-9904-925c7caca936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9db8b17-88bf-4342-901a-5cb7f6f2615e" xlink:to="loc_us-gaap_ReceivablesNetCurrent_f6e906b2-1797-4046-9904-925c7caca936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_387838af-1fff-4ff6-843f-9f6a512a8651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9db8b17-88bf-4342-901a-5cb7f6f2615e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_387838af-1fff-4ff6-843f-9f6a512a8651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_39cb6e02-9200-4103-ab8e-2fec3ed25c26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9db8b17-88bf-4342-901a-5cb7f6f2615e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_39cb6e02-9200-4103-ab8e-2fec3ed25c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_ebdb48eb-1d14-4141-8f64-e23bf0511684" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9db8b17-88bf-4342-901a-5cb7f6f2615e" xlink:to="loc_us-gaap_ContractWithCustomerLiability_ebdb48eb-1d14-4141-8f64-e23bf0511684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofsupplementalfinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#CollaborationandlicenseagreementsScheduleofsupplementalfinancialinformationrelatedtocollaborationandlicenseagreementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofsupplementalfinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_df0deec0-065b-4998-8cfe-14b489628b81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_543327c5-84f0-4923-bb22-099a39b8befa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_df0deec0-065b-4998-8cfe-14b489628b81" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_543327c5-84f0-4923-bb22-099a39b8befa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockholdersequityDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#StockholdersequityDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockholdersequityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_70d8872d-54e8-4707-8208-589dd01ff338" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6c8ba557-e4e6-4077-806f-0589d4dee3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_70d8872d-54e8-4707-8208-589dd01ff338" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6c8ba557-e4e6-4077-806f-0589d4dee3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_057a0d28-41ea-46e6-82bb-8865276246ef" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6c8ba557-e4e6-4077-806f-0589d4dee3fd" xlink:to="loc_srt_RangeAxis_057a0d28-41ea-46e6-82bb-8865276246ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_730ae018-d75a-479c-b2bd-59447c586c29" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_057a0d28-41ea-46e6-82bb-8865276246ef" xlink:to="loc_srt_RangeMember_730ae018-d75a-479c-b2bd-59447c586c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dc6d36c4-4007-4b47-8120-40d8d44f8d3e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_730ae018-d75a-479c-b2bd-59447c586c29" xlink:to="loc_srt_MaximumMember_dc6d36c4-4007-4b47-8120-40d8d44f8d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fee4b326-a1b3-43ac-9956-8dea409e4e42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6c8ba557-e4e6-4077-806f-0589d4dee3fd" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fee4b326-a1b3-43ac-9956-8dea409e4e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c2d13f16-21e2-49fd-844f-ea6730320c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fee4b326-a1b3-43ac-9956-8dea409e4e42" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c2d13f16-21e2-49fd-844f-ea6730320c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AtTheMarketMember_6d969678-fc73-4a88-a95d-f6c1470eb91b" xlink:href="cccc-20240331.xsd#cccc_AtTheMarketMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c2d13f16-21e2-49fd-844f-ea6730320c1e" xlink:to="loc_cccc_AtTheMarketMember_6d969678-fc73-4a88-a95d-f6c1470eb91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_1e5f8750-6bea-4630-a5cb-ad88cb062770" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6c8ba557-e4e6-4077-806f-0589d4dee3fd" xlink:to="loc_us-gaap_TypeOfArrangementAxis_1e5f8750-6bea-4630-a5cb-ad88cb062770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_fdfce435-0839-4aec-a768-e30db68a1ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_1e5f8750-6bea-4630-a5cb-ad88cb062770" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_fdfce435-0839-4aec-a768-e30db68a1ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EquityDistributionAgreementWithCowenAndCompanyLLCMember_593bde59-04a1-4c3b-93f0-26d94e808669" xlink:href="cccc-20240331.xsd#cccc_EquityDistributionAgreementWithCowenAndCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_fdfce435-0839-4aec-a768-e30db68a1ee0" xlink:to="loc_cccc_EquityDistributionAgreementWithCowenAndCompanyLLCMember_593bde59-04a1-4c3b-93f0-26d94e808669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_437158ef-827b-4d53-a468-539967a4f105" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6c8ba557-e4e6-4077-806f-0589d4dee3fd" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_437158ef-827b-4d53-a468-539967a4f105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_8c985c04-58d6-47d4-9a55-9297533d3afc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_437158ef-827b-4d53-a468-539967a4f105" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_8c985c04-58d6-47d4-9a55-9297533d3afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6a206738-e30b-4ea5-8045-f042e80360f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_437158ef-827b-4d53-a468-539967a4f105" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6a206738-e30b-4ea5-8045-f042e80360f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_1092d3b4-8072-4fef-b965-0a355ebd7ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_437158ef-827b-4d53-a468-539967a4f105" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_1092d3b4-8072-4fef-b965-0a355ebd7ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationScheduleofstockbasedcompensationexpenseDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#StockbasedcompensationScheduleofstockbasedcompensationexpenseDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationScheduleofstockbasedcompensationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a2c2e5b-30f2-4d0b-9c52-78bceb1dbdfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_37b2318f-8689-46ac-8677-f134b3107c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a2c2e5b-30f2-4d0b-9c52-78bceb1dbdfa" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_37b2318f-8689-46ac-8677-f134b3107c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_64c50eaf-b758-4769-a1ed-45b5a3e5aeca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_37b2318f-8689-46ac-8677-f134b3107c1e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_64c50eaf-b758-4769-a1ed-45b5a3e5aeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_36591db6-d8fc-4bac-aeff-8ed633ad0a80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_64c50eaf-b758-4769-a1ed-45b5a3e5aeca" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_36591db6-d8fc-4bac-aeff-8ed633ad0a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c0272d94-ad0e-46e5-a94e-9b2111a98c27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_36591db6-d8fc-4bac-aeff-8ed633ad0a80" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c0272d94-ad0e-46e5-a94e-9b2111a98c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_95d889b0-0af3-4f2c-8e8d-a02ab3428b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_36591db6-d8fc-4bac-aeff-8ed633ad0a80" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_95d889b0-0af3-4f2c-8e8d-a02ab3428b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd256f-5dc4-4981-9a64-d593a0c5e498" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_37b2318f-8689-46ac-8677-f134b3107c1e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd256f-5dc4-4981-9a64-d593a0c5e498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_362d2c32-134e-453e-b8ba-a002b03e5e97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_06dd256f-5dc4-4981-9a64-d593a0c5e498" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_362d2c32-134e-453e-b8ba-a002b03e5e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationNarrativeDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#StockbasedcompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4960da4b-f3c6-459a-96a9-32ce555b593f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6c4f961-acbc-40e3-87e6-a06dd5f62215" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4960da4b-f3c6-459a-96a9-32ce555b593f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6c4f961-acbc-40e3-87e6-a06dd5f62215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a0e36cc5-2924-4e0d-8ece-a425ff66b719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6c4f961-acbc-40e3-87e6-a06dd5f62215" xlink:to="loc_us-gaap_AwardTypeAxis_a0e36cc5-2924-4e0d-8ece-a425ff66b719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_361d2220-4c9e-4847-91a0-474f1aa1fca4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a0e36cc5-2924-4e0d-8ece-a425ff66b719" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_361d2220-4c9e-4847-91a0-474f1aa1fca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_939b8bc6-e04c-424b-b2a0-c75df6d8a7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_361d2220-4c9e-4847-91a0-474f1aa1fca4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_939b8bc6-e04c-424b-b2a0-c75df6d8a7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_18f67af2-813b-450e-95f8-35f9dce093e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_361d2220-4c9e-4847-91a0-474f1aa1fca4" xlink:to="loc_us-gaap_PerformanceSharesMember_18f67af2-813b-450e-95f8-35f9dce093e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c20ca913-8754-40a1-8156-2996d6bae346" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_361d2220-4c9e-4847-91a0-474f1aa1fca4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c20ca913-8754-40a1-8156-2996d6bae346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d11fa872-bd85-4b48-b3dd-109113f242f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6c4f961-acbc-40e3-87e6-a06dd5f62215" xlink:to="loc_us-gaap_PlanNameAxis_d11fa872-bd85-4b48-b3dd-109113f242f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c6b64b7c-66a7-4105-9d96-c7c41ca8a8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d11fa872-bd85-4b48-b3dd-109113f242f4" xlink:to="loc_us-gaap_PlanNameDomain_c6b64b7c-66a7-4105-9d96-c7c41ca8a8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_7d5ae79e-65e5-4b20-a2a3-e4aa407db64d" xlink:href="cccc-20240331.xsd#cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c6b64b7c-66a7-4105-9d96-c7c41ca8a8f5" xlink:to="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_7d5ae79e-65e5-4b20-a2a3-e4aa407db64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6c4f961-acbc-40e3-87e6-a06dd5f62215" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_63b2ea76-8f5e-4071-a27e-110142851053" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_63b2ea76-8f5e-4071-a27e-110142851053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_de2391c2-9bdf-4957-8435-278c8c76a656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_de2391c2-9bdf-4957-8435-278c8c76a656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4fc172c7-1c2e-4491-9432-c25685f46dca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4fc172c7-1c2e-4491-9432-c25685f46dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1625856b-d667-4f05-9a08-3fc15edd3050" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1625856b-d667-4f05-9a08-3fc15edd3050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_696c7ced-1e38-4af2-a2a8-09aa5a93cb95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_696c7ced-1e38-4af2-a2a8-09aa5a93cb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNewExercisePricePerShareTrancheOne_75f41e7a-4a42-4a29-a6bb-97a85cdd9f05" xlink:href="cccc-20240331.xsd#cccc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNewExercisePricePerShareTrancheOne"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_cccc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNewExercisePricePerShareTrancheOne_75f41e7a-4a42-4a29-a6bb-97a85cdd9f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNewExercisePricePerShareTrancheTwo_37d66d5f-104f-4bfe-b765-6b3aeab87902" xlink:href="cccc-20240331.xsd#cccc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNewExercisePricePerShareTrancheTwo"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_cccc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNewExercisePricePerShareTrancheTwo_37d66d5f-104f-4bfe-b765-6b3aeab87902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_bd91b4a3-10a0-40aa-8a8d-15c0f0ffcee8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_bd91b4a3-10a0-40aa-8a8d-15c0f0ffcee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dc4a0f70-0c6d-4c3f-9b55-3c73f84e5202" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dc4a0f70-0c6d-4c3f-9b55-3c73f84e5202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonStockIssuablePerRSUVested_f3bb1f87-1f5c-4a30-ae14-c361a405802e" xlink:href="cccc-20240331.xsd#cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonStockIssuablePerRSUVested"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonStockIssuablePerRSUVested_f3bb1f87-1f5c-4a30-ae14-c361a405802e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_88685872-11f5-4b29-8f70-f7ad8512bfba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_88685872-11f5-4b29-8f70-f7ad8512bfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_197a3891-22b8-449c-a04b-b90bf6774906" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aedf79df-cf60-4afd-9e09-a2e182bfb23a" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_197a3891-22b8-449c-a04b-b90bf6774906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LosspershareScheduleofdilutednetlosspershareattributabletocommonstockholdersDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#LosspershareScheduleofdilutednetlosspershareattributabletocommonstockholdersDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LosspershareScheduleofdilutednetlosspershareattributabletocommonstockholdersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_74e74b1b-df56-49f3-85fb-8cec65be08a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f5b16f1d-1b7f-4fe6-98bb-9a6e3226b08d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_74e74b1b-df56-49f3-85fb-8cec65be08a4" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f5b16f1d-1b7f-4fe6-98bb-9a6e3226b08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c630deb2-e166-46b4-a5b8-1d5644d9d2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f5b16f1d-1b7f-4fe6-98bb-9a6e3226b08d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c630deb2-e166-46b4-a5b8-1d5644d9d2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a20e4864-1d29-4dfc-985a-856a8fdab42e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c630deb2-e166-46b4-a5b8-1d5644d9d2d3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a20e4864-1d29-4dfc-985a-856a8fdab42e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OptionsToPurchaseCommonStockMember_d623151c-3ed6-4235-b3df-9dcccd6b0808" xlink:href="cccc-20240331.xsd#cccc_OptionsToPurchaseCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a20e4864-1d29-4dfc-985a-856a8fdab42e" xlink:to="loc_cccc_OptionsToPurchaseCommonStockMember_d623151c-3ed6-4235-b3df-9dcccd6b0808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_705612f7-9ff6-4da9-b162-a27dfe40d2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f5b16f1d-1b7f-4fe6-98bb-9a6e3226b08d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_705612f7-9ff6-4da9-b162-a27dfe40d2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_299c18fb-303c-40da-b8f1-37d0976a6dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_705612f7-9ff6-4da9-b162-a27dfe40d2eb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_299c18fb-303c-40da-b8f1-37d0976a6dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LosspershareScheduleofbasicanddilutedlosspershareDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#LosspershareScheduleofbasicanddilutedlosspershareDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LosspershareScheduleofbasicanddilutedlosspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8f5676b0-f9ef-4602-a65d-90724195acc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_d2f2e061-c992-4c86-a55d-0dd66e0485fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f5676b0-f9ef-4602-a65d-90724195acc9" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_d2f2e061-c992-4c86-a55d-0dd66e0485fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b5039ccf-9604-4dbc-adfc-c7165fe8a49e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_d2f2e061-c992-4c86-a55d-0dd66e0485fe" xlink:to="loc_us-gaap_NetIncomeLoss_b5039ccf-9604-4dbc-adfc-c7165fe8a49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3581b758-2cc1-4c4f-9115-475d1da9813d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f5676b0-f9ef-4602-a65d-90724195acc9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3581b758-2cc1-4c4f-9115-475d1da9813d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_71525fc7-da06-4032-aa69-e9744016ef8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3581b758-2cc1-4c4f-9115-475d1da9813d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_71525fc7-da06-4032-aa69-e9744016ef8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_df171953-7fa9-4ed6-9833-562537dbe9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3581b758-2cc1-4c4f-9115-475d1da9813d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_df171953-7fa9-4ed6-9833-562537dbe9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_acd69be9-d723-4c1d-9769-2c8aa1123f65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f5676b0-f9ef-4602-a65d-90724195acc9" xlink:to="loc_us-gaap_EarningsPerShareBasic_acd69be9-d723-4c1d-9769-2c8aa1123f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f766bc33-f3b8-4d35-acfe-c06444a693ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8f5676b0-f9ef-4602-a65d-90724195acc9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f766bc33-f3b8-4d35-acfe-c06444a693ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncometaxesDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#IncometaxesDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncometaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2d508668-e5d0-4a5a-9cee-6f8aa2d94725" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e43ccde5-999c-4424-bc87-02b5c9637d77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2d508668-e5d0-4a5a-9cee-6f8aa2d94725" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e43ccde5-999c-4424-bc87-02b5c9637d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/RestructuringDetails" xlink:type="simple" xlink:href="cccc-20240331.xsd#RestructuringDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/RestructuringDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_aa4ae5ef-3b1d-461e-8043-81eb12cd7330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_5d8589f3-9cfe-4909-a101-d2738f728085" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_aa4ae5ef-3b1d-461e-8043-81eb12cd7330" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_5d8589f3-9cfe-4909-a101-d2738f728085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_0003cc6f-229c-467d-9b25-6c65dd776e61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_aa4ae5ef-3b1d-461e-8043-81eb12cd7330" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated_0003cc6f-229c-467d-9b25-6c65dd776e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_b0036e26-6665-4848-89a3-2d44fa59b509" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_aa4ae5ef-3b1d-461e-8043-81eb12cd7330" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_b0036e26-6665-4848-89a3-2d44fa59b509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_5d5d4777-5347-46b4-a35d-4eaec8d37f17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_aa4ae5ef-3b1d-461e-8043-81eb12cd7330" xlink:to="loc_us-gaap_RestructuringReserveCurrent_5d5d4777-5347-46b4-a35d-4eaec8d37f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
